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Summary 
Helminths cause so-called neglected tropical diseases in tropical and sub-tropical regions 
and are prevalent in almost one third of mankind. Thus, co-infections of helminths with 
other pathogens are common. However, the effects of helminths on outcomes of 
infections with unrelated pathogens like bacteria are rather poorly understood and 
underrepresented in biomedical research. In this thesis it was investigated, how chronic 
filarial infection influences acute bacterial challenge infections. To achieve this, mice 
chronically infected with the filarial nematode Litomosoides sigmodontis (L.s.) were 
intraperitoneally challenged with the gram-negative bacterium Escherichia coli. Sepsis 
severity was determined by survival, development of hypothermia, systemic pro-
inflammatory cytokine and chemokine levels. Clearance of bacteria and recruitment of 
immune cells to the peritoneum were determined 6 hours after bacterial challenge. The 
role of nematode-induced immune cell populations as regulatory T cells, eosinophils and 
macrophages and their receptors (e.g. Toll-like receptor 2, IL-4 receptor) were investigated 
using various gene-deficient mouse strains. In order to further elucidate the protective 
mechanisms, in vitro studies and adoptive cell transfers were performed. 
This thesis demonstrates that chronic infection with the filarial nematode L. sigmodontis 
provides a significant survival benefit to E. coli-induced sepsis in mice. This was 
accompanied by attenuated hypothermia and reduced systemic cytokine/chemokine 
secretion. Chronically L.s.-infected mice displayed an improved bacterial control and 
increased recruitment of neutrophils and eosinophils, which was accompanied by a 
reduced activation and apoptosis of peritoneal macrophages. Depletion of macrophages by 
Clodronate liposomes indicated a protective role of macrophages in the L.s.-mediated 
protection against E. coli-induced sepsis. L.s. infection induced RELM expression on 
peritoneal macrophages in wildtype BALB/c mice following E. coli challenge, indicating a 
possible switch to an alternatively activated macrophage (AAM) phenotype. However, L.s.-
infected IL-4R/IL-5-/- and IL-4-/- mice that were devoid of AAM were still protected from E. 
coli sepsis. These experiments suggest that the presence of macrophages is necessary, but 
the induction of an AAM phenotype is not required to improve sepsis outcome by L.s. 
infection.  
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Most filarial species have endosymbiotic Wolbachia bacteria that activate innate cells and 
reduce subsequent responses to innate stimuli via Toll-like receptor 2 (TLR2). In vitro 
stimulation with Wolbachia-containing preparations in wildtype but not TLR2-deficient 
macrophages reduced TNF secretion following LPS-restimulation. These macrophages 
showed enhanced phagocytosis and uptake of bacteria and produced more bactericidal 
nitric oxide in a TLR2 dependent manner. Accordingly, the protective effect of chronic L.s. 
infection was lost in TLR2-deficient mice promoting a concept of Wolbachia- and TLR2-
mediated immune modulation. Moreover, repeated injections of L.s. and Wolbachia-
derived preparations improved sepsis outcome in a TLR2-dependent manner. 
Finally, macrophage transfer experiments demonstrated that macrophages from L.s.-
infected mice improved sepsis outcome of recipient mice, whereas macrophages from L.s.-
infected TLR2-/- mice and naïve BALB/c mice did not significantly improve sepsis outcome in 
recipient mice. 
This thesis provides immunologic insight to the complex interplay of filarial and bacterial 
co-infection and demonstrates a filariae- and Wolbachia-induced mechanism that protects 
mice via a dual beneficial effect on phagocytes, which permits improved containment of 
bacteria and reduced systemic inflammation. This may help to find new therapeutic 
interventions to prevent severe sepsis also in human patients. 
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1 Introduction 
1.1 New therapies to treat and prevent sepsis are required 
Sepsis represents a state of systemic inflammation, usually triggered by bacteria and their 
toxins, although fungi- and virus-induced sepsis also exists. Sepsis is a severe, life-
threatening condition characterized by pathophysiological changes. Those changes can 
include fever or hypothermia, hypotension, hypoxia, abundant agglutination and excessive 
secretion of pro-inflammatory cytokines eventually leading to organ failure and death 
(Angus and van der Poll, 2013; Hotchkiss and Karl, 2003). Importantly, in most cases it is 
not the pathogen that kills the patient, but rather a dysregulated host response that 
compromises organ function with detrimental effects for the patient’s health (first stated 
by Sir William Osler in 1894). Prevalence of sepsis increased over the last decades, while 
mortality rates declined and costs per patients rose (Angus and Wax, 2001; Artero et al., 
2008; Beale et al., 2009; Martin et al., 2003). Sepsis still represents a major health problem 
and a high risk factor for post-surgical complications (Lichtenstern et al., 2007), especially 
for immunocompromised and newborn patients (Koch, 2015). For example 150.000 cases 
of sepsis are reported in Germany per year, while mortality of severe cases is about 50% 
(Engel et al., 2007). Despite immense efforts in basic and clinical research, sepsis is the 
most prevalent cause of death of critically ill patients in intensive care units today (Alberti 
et al., 2003; Martin et al., 2003; Rittirsch et al., 2008a). Current treatment strategies are 
limited to administration of adequate antibiotics and stabilization measures as fluid 
resuscitation and ventilation. As various therapeutic approaches that aimed to improve 
sepsis survival by dampening systemic inflammation have failed so far (Iskander et al. 2013; 
Marshall 2014; Suffredini & Munford 2011), new strategies to treat and prevent sepsis are 
highly required. 
 
1.2 Filarial infections: pathology, treatment, immune modulation and an 
experimental model 
1.2.1 Filarial infections cause distinctive pathologies in humans 
Human pathogenic filarial nematodes are roundworms that mainly occur in tropical and 
subtropical regions of central Africa, Asia as well as Central and South America. Those 
1 Introduction 
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infections are transmitted by blood-feeding insects as vectors (e.g. Simulium, Culex, 
Anopheles, Aedes, Culicoides).  
Commonly, infective stage 3 larvae (L3) are transmitted to a new host by the appropriate 
blood feeding insect vector. These larvae migrate to species-specific sites (see below), 
where they molt twice into adult worms. Female and male adult worms mate and females 
release first stage larvae, termed “microfilariae” (mf). Dependent on the species, mf are 
found in the peripheral blood or the skin, where they can be taken up by the vector. In the 
insect vector mf develop into the infective L3 stage, which then can be transmitted to a 
new definitive host with the next blood meal. 
Human pathogenic filariae can cause several clinical manifestations. Lymphatic filariasis is 
caused by Wuchereria bancrofti, Brugia malayi and Brugia timori. These parasites reside in 
the lymphatic vessels of human hosts, leading to lymphedema in extremities 
(elephantiasis) or scrotum (hydrocele) (Pfarr et al., 2009). In the past 15 years lymphatic 
filariasis was endemic in 73 countries in the world and mass drug administration programs 
succeeded to reduce the global prevalence from 3.55% to 1.47%. Whereas, a total number 
of 128 million lymphatic filariasis-infected patients was estimated in 1997, this number 
declined based on a recent calculation to 67.88 million patients (Manson's Tropical 
Infectious Diseases; Ramaiah and Ottesen, 2014). 
Several filarial species dwell in skin-associated tissues like subcutis and dermis. The adult 
worms of Onchocerca volvulus reside in palpable nodules in the subcutis. The disease is 
also called “River Blindness” since microfilariae can migrate to the eyes and induce 
inflammatory responses that may lead to vision loss. Importantly, the release of 
endosymbiotic Wolbachia bacteria and their products was shown to initiate toll-like 
receptor 2 (TLR2)-driven inflammation leading to inflammatory processes that can lead to 
blindness (Saint André et al., 2002; Gillette-ferguson et al., 2004; Tamarozzi et al., 2011). 
Onchocerciasis is endemic in Sub-Saharan Africa, Yemen and some foci in Latin America. In 
2005 a total number of 37 million humans were estimated to be infected with O. volvulus 
(WHO, Manson's Tropical Infectious Diseases). 
Another skin associated filarial nematode is Loa loa, which causes Loiasis. Loa loa adults 
migrate through the subcutaneous tissues and may occasionally be found in the eyes and is 
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therefore called “eyeworm”. Of note, unlike the majority of filarial species, Loa loa does 
not harbor Wolbachia endosymbionts (Büttner et al., 2003; Desjardins et al., 2013). 
Mansonella perstans is a filarial nematode whose adult worms reside in the serous cavity 
(abdomen, peritoneum). Infections with M. perstans cause relatively mild symptoms and 
are often undiagnosed. Occurrence of Wolbachia was described for M. perstans, however, 
regional differences seem to exist (Büttner et al., 2003; Grobusch et al., 2003; Hoerauf, 
2009; Keiser et al., 2008). 
 
1.2.2 Wolbachia, endobacteria with implications for symbiosis, pathology and 
drug-targeting in filariasis 
Wolbachia are alpha-proteobacteria which belong to the family of Rickettsiacea. Besides 
insects, several filarial nematodes (e.g. W. bancrofti, Brugia spp., O. volvulus, L. 
sigmodontis) harbor Wolbachia in an obligate endosymbiotic manner. The Wolbachia 
endosymbionts are required for the reproduction of the filariae and provide metabolites 
that cannot be synthesized by their hosts (Comandatore et al., 2013; Darby et al., 2012; 
Taylor et al., 2005b). This metabolic mutualism makes Wolbachia and their metabolism an 
elegant chemo-therapeutic target for anti-filarial drugs, especially due to their macro-
filaricidal effect (Hoerauf, 2000; Hoerauf et al., 2011, 2001, 2008; Lentz et al., 2013; 
Schiefer et al., 2013; Taylor et al., 2014; Walker et al., 2014). 
Wolbachia are further involved in the development of pathology during filarial infection 
(Genchi et al., 2012; Hoerauf et al., 2002; Katawa et al., 2015; Tamarozzi et al., 2011; 
Turner et al., 2009). Thus, several studies demonstrated that severe forms (e.g. vision loss 
and dermatitis) and complications of anti-helminthic drug treatment can be linked to the 
release of Wolbachia from dying worms and associated inflammatory responses (Saint 
André et al., 2002; Gillette-ferguson et al., 2004; Keiser et al., 2002; Tamarozzi et al., 2011; 
Turner et al., 2009). Wolbachia trigger pro-inflammatory responses after binding a receptor 
complex formed by TLR2, TLR6, and CD14, and signaling via MyD88 and Mal. TLR1, TLR4, 
TRAM and TRIF are not required for Wolbachia-induced immune responses (Hise et al., 
2007). In vitro, Wolbachia derived products induced the release of IL-6 and TNF as well as 
the upregulation of surface-expressed co-stimulatory molecules in both human and murine 
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mononuclear phagocytes (Daehnel et al., 2007; Gillette-Ferguson et al., 2007; Hise et al., 
2007; Turner et al., 2006). During early infection, Wolbachia-induced mast cell activation 
was further shown to increase vascular permeability in the skin, thereby promoting larval 
entry (Specht et al., 2011). 
 
1.2.3 Options for anti-filarial treatment 
Anti-filarial drugs are rather broad-spectrum than specific to certain species. For instance, 
Albendazole and Ivermectin are effective against a range of parasitic nematodes and are 
used in humans as well as veterinary medicine (pets and life stock). Historically, 
Diethycarbamazine (DEC) was used for almost all helminth infections. Today, DEC is not 
recommended for mass drug administration in areas where Onchocerciasis is present, since 
the rapid killing of O. volvulus microfilariae by DEC can cause strong inflammatory immune 
responses that may lead to urticaria (Mazzotti reaction), permanent eye damage and even 
death (Keiser et al., 2002). 
The use of antibiotics has become an alternative or additional treatment option for filariae 
that contain endosymbiotic Wolbachia bacteria (Hoerauf, 2008; Hoerauf et al., 2011; 
Johnston et al., 2014). Since in most cases Wolbachia endosymbionts are required for the 
filarial development, antibiotics like Doxycyclin are effective for anti-filarial therapy. 
Importantly, those drugs have microfilaricidal as well as macrofilaricidal effects and allow 
therefore to stop the transmission between individuals, reduce the time required for 
elimination by mass drug administration, as well as a reduction of disease burdens in 
patients (Hoerauf, 2000; Hoerauf et al., 1999, 2001, 2008; Mand et al., 2009; Taylor et al., 
2014; Volkmann et al., 2003a). 
 
1.2.4 Effects of helminth-induced immune modulation on bystander responses 
Helminth infections induce type 2 immune responses which are characterized by the 
induction of T helper 2 cells, eosinophilia and elevated serum IgE levels as well as the Th2-
associated cytokines IL-4, IL-5 and IL-13 (Maizels et al., 2004). To ensure long term host-
parasite coexistence, helminths suppress inflammatory immune responses and thereby 
limit pathology. Thus, helminths establish a hypo-responsive milieu in their hosts by 
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inducing regulatory T cells, alternatively activated macrophages (AAM) as well as the 
release of the anti-inflammatory cytokines IL-10 and TGFβ ,which impact adaptive and 
innate immunity (Allen and Maizels, 2011; Anthony et al., 2007; Doetze et al., 2000; 
Hoerauf et al., 2005; Taylor et al., 2006).  
The immunomodulation by helminths reduces bystander immune responses and can have 
protective effects on autoimmune diseases (Bashi et al., 2014; Cooke et al., 1999; Hübner 
et al., 2009, 2012a; Matisz et al., 2011; Summers et al., 2005) and allergies (Dittrich et al., 
2008; Erb, 2009; Wilson et al., 2005). These may be attenuated, delayed in onset or even 
totally blocked. On the other hand, efficacy of vaccination is reduced in helminth-infected 
individuals (Cooper et al., 1998; Hartmann et al., 2011, 2013; Jackson et al., 2009).  
Several of these findings are now translated to human patients with autoimmune diseases. 
A range of clinical trials is currently testing the potential of Trichuris suis ova therapy to 
improve autoimmune (e.g. multiple sclerosis) and auto-inflammatory diseases (e.g. Crohn’s 
disease), as well as atopy and allergic responses (e.g. allergic rhinitis) (Bager et al., 2010; 
Rosche et al., 2013; Wammes et al., 2014; Weinstock and Elliott, 2013). 
 
1.2.5 Filaria-derived products skew immune responses towards Th2 immunity 
Filarial nematodes release and secrete molecules that help the parasites to establish and 
sustain immunomodulation in their hosts. Since there are no simple techniques to 
distinguish between actively secreted molecules and molecules that are released passively 
at events like molting or release of microfilariae, all filaria-released molecules are in 
general termed excretory/secretory products (E/S products). These products may exert 
their function through enzymatic activity or receptor ligation to establish an immunological 
niche, commonly characterized by a modified Th2 response, downregulated Th1- and Th17-
responses and induction of lymphangiogenesis as well as regulatory functions in a range of 
immune cells of both lymphoid and myeloid origin (Weinkopff et al., 2014).  
Various filaria-derived proteins have been found to influence immune responses to 
bystander antigens in a range of (auto-) inflammatory diseases (Daniłowicz-Luebert et al., 
2011; Hewitson et al., 2009). The most prominent protein in infective stage L3 larvae of 
filarial species is ALT (abundant larval transcript-1). No mammalian homologue has been 
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found to date and it has therefore been widely tested as anti-filarial vaccine candidate in 
various experimental models with variable success (Babayan et al., 2012). Cystatins are a 
class of cysteine protease inhibitors (CPI) secreted by a range of helminth species 
(Hartmann et al., 1997; Pfaff et al., 2002; Sun et al., 2013) and has homologs in mammals. 
In animal models of autoimmunity, administration of filaria-derived recombinant CPI has 
been shown to improve disease outcomes. Filarial CPI induced Interleukin 10-producing 
macrophages that mediate the attenuation of allergic and inflammatory responses (Klotz et 
al., 2011; Schnoeller et al., 2008; Ziegler et al., 2015). Furthermore, CPI was shown to 
prevent MHC class II restricted antigen processing and presentation via the inhibition of 
peptidase activity of asparaginyl-endopeptidase (Gregory and Maizels, 2008). In another 
approach CPI was successfully used as vaccine for L. sigmodontis challenge infections 
(Babayan et al., 2012). An excretory/secretory product derived from Acanthocheilonema 
viteae with the molecular weight of 62 kDa (termed ES-62) is a glycoprotein that contains 
phosphorylcholine moieties. ES-62 has a broad spectrum of target cells (e.g. T and B cells, 
macrophages, mast cells) and signaling mechanisms (e.g. via TCR, BCR, TLRs/MyD88, FcR1) 
and has been demonstrated to impact a wide range of allergic and inflammatory diseases 
(Pineda et al., 2014). Importantly, macrophage production of cytokines like IL-6 and TNF 
in response to LPS, CpG or bacterial lipopeptide is suppressed by ES-62 by binding to TLR4 
(Goodridge et al., 2001, 2005). 
 
1.2.6 Infections with parasitic nematodes affect outcomes of bacterial co-
infections 
Several epidemiological reports and animal studies have demonstrated that immune 
responses to concurrent bacterial infections can be altered by helminths. The associated 
consequences are highly context-dependent and can be either beneficial or detrimental for 
the host (Hübner et al., 2013; Panda et al., 2013; Salgame et al., 2013). 
Animal models investigating the effect of established helminth infections on acute bacterial 
challenges brought up diverse results, suggesting that the outcome is probably highly 
dependent on both the helminth and bacterial species investigated (Hübner et al., 2013; 
Salgame et al., 2013). Helminth species differ in their location within the host, their 
migratory pathways, the duration of infection and the pathology they induce. This affects 
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both, systemic and local immune responses within the host. Similarly, immune responses 
to different bacterial infections vary. For instance, protective immunity against 
intracellularly replicating bacteria employs different defense mechanisms as anti-bacterial 
responses to extracellularly living bacteria. In the case of Mycobacterium infections 
profound Th1 responses that utilize Interferon (IFN)provide protection. A pre-existing 
helminth infection may thereby skew the immune system towards a Th2 or regulatory 
state that may hamper protective Th1 immunity to Mycobacteria (Chatterjee and Nutman, 
2015; Elias et al., 2007; Potian et al., 2011; Rook, 2009). Although this paradigm was proven 
in some experimental models (Elias et al., 2007; Metenou S, Babu S, 2012; Resende Co et 
al., 2007), other studies using different helminth species did not find an increased 
susceptibility to Mycobacteria, but rather improved bacterial control (Erb et al., 2002; 
Frantz et al., 2007; Hübner et al., 2012b; du Plessis et al., 2012; Rafi Wasiulla, Bhatt 
Kamlesh, Gause William C., 2015). Similarly, in Heligmosoides polygyrus-infected mice 
intracellular killing of Citrobacter rodentium is hampered due to impaired autophagy of 
alternatively activated macrophages (AAM) in an IL-4 receptor- and signal transducer and 
activator of transcription 6 (STAT6)-dependent manner (Su et al., 2012). On the other hand, 
Nippostrongylus brasiliensis-infection has a protective effect on Klebsiella pneumoniae-
induced septic peritonitis by mast cell modulation via IL-4 (Sutherland et al., 2011). Other 
features of helminth and bacterial strains also contribute to the diverse outcomes of co-
infection models: For instance, intestinal helminths damage intestinal barriers and thereby 
cause dissemination of enteric bacteria that induce initial inflammation and may modulate 
subsequent TLR responses (Chen et al., 2006; Farid et al., 2008). The potential of bacteria 
to induce a systemic cytokine storm and sepsis is also an important parameter that may 
influence the outcome of co-infection models. A study that determined the outcomes of 
several bacterial infection models in Taenia crassiceps- and H. polygyrus-infected mice 
reported that both helminth infections predispose mice to pneumococcal infections, 
whereas protective immunity to Staphylococcus aureus and Listeria monocytogenes was 
not impaired (Apiwattanakul et al., 2014). This underlines the fact that outcomes in co-
infection models are highly dependent on the respective immune responses and their 
interference. 
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1.2.7 Litomosoides sigmodontis: an experimental model for human filariasis and 
filariae-induced immune modulation 
Modelling filarial infection in laboratory animals is a critical requisite for the development 
of anti-filarial drugs and deeper parasitological and immunological investigations. Human 
pathogenic filariae do not develop in immunocompetent laboratory mice and studies using 
implantation of worms have several caveats that hamper unequivocal conclusions.  
The filarial nematode Litomosoides sigmodontis (L.s.) patently infects laboratory rodents 
and shares important features with human-pathogenic filariae. Transmission by an 
arthropod vector, larval development and circulating microfilariae are common 
characteristics. L.s. harbors Wolbachia-endosymbionts like most human-pathogenic filariae 
and several immune characteristics also match: induction of a regulatory immune setting, 
increased serum IgE and IL-5 levels, eosinophilia and expansion of alternatively activated 
macrophages (AAM) and regulatory T cells (Treg). The natural host of L.s. is the cotton rat 
(Sigmodon hispidus). L.s. infects gerbils (Meriones unguiculatus) and certain laboratory 
mouse strains like the BALB/c strain (Allen et al., 2008; Hoffmann et al., 2000). Infectious 
L.s. L3 larvae are transmitted by the tropical rat mite (Ornithonyssus bacoti) into the host’s 
skin. Transmitted larvae migrate via the lymphatics to the pleural cavity and molt twice to 
become adult worms. After mating, female worms start to release microfilariae at ~60 days 
post infection, which then enter the peripheral blood. Microfilariae can be taken up by 
blood feeding mites and develop into infective L3 larvae that can be transmitted to a new 
host. Adult worms live in the pleural cavity for several months. Over time, increasing 
numbers of immune cells like eosinophils, neutrophils and macrophages are recruited to 
the pleural cavity and granulomas are formed around the worms and clear the infection 
over time.  
Since L. sigmodontis establishes fully patent infections in BALB/c mice, it is a powerful tool 
to identify new anti-filarial drugs and investigate vaccination regimens. Especially, the 
impact on both, microfilarial and macrofilarial burdens can be studied in experimental 
infections with L. sigmodontis (Babayan et al., 2012; Hoerauf et al., 1999; Hübner et al., 
2010; Ziewer et al., 2012). 
L.s. infections were further used to identify specific immune parameters and their 
contributions to the different phases of filarial infection (Ajendra et al., 2014; Al-Qaoud et 
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al., 1997; Saeftel et al., 2001; Specht et al., 2006, 2011; Torrero et al., 2010; Volkmann et 
al., 2003b).  
The impact of concurrent filarial infection on vaccination efficacy to unrelated antigens was 
also investigated in the murine system using various model antigens and vaccination 
regiments. A reduction in vaccination efficacy was associated with suppressed T cell 
proliferation and Ig production with a role for IL-10 (Hartmann et al., 2011; Kolbaum et al., 
2012). In co-infection models L.s. was associated with reduced mortality in Plasmodium 
berghei challenged mice (Specht et al., 2010). Similarly, chronic L.s. infection was shown to 
have beneficial effects on M. tuberculosis infections in cotton rats (Hübner et al., 2012b).  
L. sigmodontis was used to experimentally induce certain immunomodulatory cell 
populations to further study their individual identity and behavior. L.s. induces regulatory T 
cells and alternatively activated macrophage populations with specific functions and 
characteristics (Grainger et al., 2010; Jenkins et al., 2011; Taylor et al., 2005a, 2006). It was 
shown that hyporesponsiveness of CD4+ T helper cells in L.s. infected mice was partially 
dependent on TGF(Taylor et al., 2006). In a model of allergic airway inflammation L. 
sigmodontis-induced TGF and regulatory T-cells suppressed airway hyperreactivity and 
allergen-specific Ig production (Dittrich et al., 2008). Similarly, TGFβ was shown to be 
required for L. sigmodontis-mediated protection against the onset of Diabetes in NOD mice 
(Hübner et al. 2012).  
Taken together, experimental infections with L. sigmodontis are an adequate model for 
human filarial infections and anti-filarial drug and vaccine development. In order to 
investigate chronic “Th2-skewed” infection and immunomodulation L.s. represents a 
valuable tool that helps to decipher protective mechanisms in infection and immunity. 
 
1.3 Macrophages, endotoxin tolerance and nematode-derived immune 
modulators 
1.3.1 Macrophages are heterogenic in terms of origin, identity and function 
Macrophages are essentially involved in protective immune responses against bacteria and 
other pathogens. In recent years it became clear that macrophages represent a diverse and 
plastic entity, capable of initiating and modulating both innate and adaptive immune 
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responses (Biswas and Mantovani, 2010; Martinez et al., 2009; Mosser and Edwards, 2008). 
Thus, macrophage populations are not restricted to either classically activated 
macrophages (CAM) or alternatively activated macrophages (AAM), but are rather defined 
in a spectrum of activation types (Gordon and Martinez, 2010; Murray et al., 2014; Schultze 
et al., 2015; Wynn et al., 2013; Xue et al., 2014). Further, tissue macrophages can derive 
from various sources as the yolk sac and fetal liver and replenish themselves by 
proliferation, but may also be constantly replenished by bone marrow derived monocytes 
(Auffray et al., 2009; Ginhoux and Jung, 2014; Guilliams et al., 2013; Perdiguero et al., 
2014; Schulz et al., 2012; Yona et al., 2013). A combination of ontogenetic differences and 
environmental stimuli derived from the respective host tissue contribute to the 
heterogeneity of macrophages and their manifold functional behavior (Gosselin et al., 
2014; Lavin et al., 2014). 
In the context of helminth infection several studies led to the consensus that IL-4-receptor-
driven activation/maturation leads to an AAM phenotype that favors wound healing and 
containment of nematode infection (Chen et al., 2012; Jenkins and Allen, 2010). 
Interestingly, investigations using L. sigmodontis infection demonstrated that filaria-
induced AAM numbers expand at the site of infection by proliferation (Jenkins et al., 2011) 
and their plasticity was highlighted by the fact that AAM can be reprogrammed by TLR 
stimulation to restore microbial killing efficacy (Mylonas et al., 2009).  
 
1.3.2 Endotoxin tolerance and negative regulation of TLR induced signals 
The phenomenon “endotoxin tolerance” describes hyporesponsive state of innate cells 
that occurs after a prior exposure to gram-negative bacteria or lipopolysaccharides (LPS). 
Similarly, various pathogen-associated molecular patterns (PAMPs), like bacterial 
lipoproteins, but also by pro-inflammatory mediators like TNF, HMGB1 and endogenous 
alarmins may induce hyporesponsiveness (Austermann et al., 2014; Biswas and Lopez-
Collazo, 2009; Cluff, 1953; Greisman et al., 1963; Hedl and Abraham, 2013; Morris et al., 
2015). To this end, induction of endotoxin tolerance is not dependent on TLR4 and LPS but 
may also be induced by several other receptors (e.g. TLR2, TNFR). TLR2-induced hypo-
responsiveness to LPS is referred to as cross-tolerance or heterotolerance (Dobrovolskaia 
et al., 2003; Lehner et al., 2001a). Endotoxin tolerant cells produce less pro-inflammatory 
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mediators and fail to upregulate co-stimulatory molecules (e.g. CD86) on their surface in 
response to the second stimulus. Endotoxin tolerance occurs also on a systemic level, as 
mice pretreated with minute amounts of LPS do not succumb to subsequent LPS challenge 
that would have been lethal in non-tolerized (i.e. naïve) mice. These mice neither show 
enhanced serum cytokine concentrations nor severe pathophysiologic symptoms. 
Therefore, LPS-tolerant mice gain a survival benefit in LPS shock experiments. Similarly, 
LPS-tolerant mice have a survival benefit for subsequent bacterial challenge infections. LPS-
tolerant mice reduce bacterial burdens more efficiently and do not show severe sepsis-
associated symptoms (Kopanakis et al., 2013; Landoni et al., 2012; Lehner et al., 2001b; 
Murphey et al., 2008; Musie et al., 2014; O’Brien et al., 2005; Shi et al., 2011; Wheeler et 
al., 2009).  
1.3.3 Intrinsic factors direct the LPS-induced signaling pathways 
The intracellular TLR signaling pathway engages TIR domain-containing adaptor molecules 
and protein kinases that lead to phosphorylation events that allow the nuclear 
translocation of the respective transcription factor and initiation of gene transcription by 
binding to specific promotor/enhancer sequences. The signaling cascade can be influenced 
by several factors: mostly kinases/phosphatases, which affect signaling events in order to 
prevent pro-inflammatory gene expression. Ubiquitin-driven proteasomal degradation is 
also significantly contributing to the termination of an immune response. 
There are various mechanisms that limit pattern recognition receptor (PRR)-driven 
activation of innate cells. Besides downregulation of surface receptors (e.g. TLR4) and 
components of the signaling cascade (e.g. MyD88, IRAK-1), expression of decoy receptors 
(e.g. soluble TLR4, SIGIRR, ST2) may prevent ligand binding and receptor complex 
formation. Soluble mediators (e.g. IL-10, TGF and IL-1RA) can act in a paracrine or 
autocrine manner to modulate PRR-derived signals. Signal transduction can be inhibited by 
intracellular and intrinsic factors that employ several different mechanisms. For example 
the ubiquitinase A20 can (de-) ubiquitinate molecules in the TLR pathway leading to 
disposal of essential signaling components. The MyD88sh splice variant of MyD88 inhibits 
signal transduction by binding of IRAK-4 and thereby hampers the association of mature 
MyD88 and IRAK-4. Similarly, IRAK-M inhibits IRAK-1 activation and deficiency of IRAK-M 
exacerbates the response to bacteria and impairs the development of endotoxin tolerance. 
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The toll interacting protein TOLLIP associates with TLR2 and TLR4 and thereby inhibits 
IRAK-1 signaling. Deficiency for TOLLIP is associated with enhanced responses to LPS, 
whereas endotoxin tolerant cells were shown to have high expression levels of TOLLIP. 
Another example is the family of suppressor of cytokine signaling (e.g. socs-1, -3), these 
molecules disrupt JAK/STAT signaling cascades and deficiency is associated with enhanced 
cytokine production and endotoxin shock in response to LPS. Examples from the previous 
paragraph are reviewed in (Biswas and Lopez-Collazo, 2009; Hedl and Abraham, 2013; 
Morris et al., 2015). 
Micro RNAs (miRNA) are small non-coding RNAs that bind their mRNA target sequence 
specifically and regulate transcription of genes through decay of mRNA. It has been 
demonstrated in various studies that miR146 and miR155 are important microRNAs that 
regulate TLR responses. For instance, miR146 represses IRAK-1 expression and reduces NF-
B driven transcription (Nahid et al., 2009). 
Epigenetic marks like DNA methylation or histone modifications also have an important 
role in regulating the expression of TLR/NFB target genes. For example, in endotoxin 
tolerant cells, methylation of histone H3 at lysine 27 (H3K27) was demonstrated at 
promoters/enhancers of LPS-induced genes (Foster et al., 2007; Netea and van Crevel, 
2014).  
Of note, there are tolerizable and non tolerizable genes, suggesting differential 
mechanisms regulating LPS-induced gene-expression and -silencing that may occur on all 
the levels mentioned above (Foster et al., 2007). 
 
1.3.4 Impact of nematode-derived molecules on TLR-mediated responses 
A range of helminth-derived molecules have been investigated to decipher the 
immunomodulatory potential of helminths to manipulate immune responses. Here, a 
special focus was put on their capacity to modulate TLR responses and outcomes in 
endotoxemia and sepsis models. 
Turner et al. (2006) revealed that Wolbachia induce tolerance to subsequent TLR- and 
CD40-specific stimulation in a TLR2 dependent manner. Macrophage pre-stimulation with 
Wolbachia-containing Brugia malayi extract diminished subsequent responses to the same 
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stimuli and to LPS in vitro and in vivo (Turner et al., 2006). This effect was linked to TLR-
mediated induction of tolerance to re-stimulation. Besides TLR2-restricted modulation of 
intracellular signaling, several helminth-derived molecules have been described to impact 
phagocyte LPS-sensing functions directly, preventing TLR activation, transcription of target 
genes and improving endotoxemia (Hübner et al., 2013). For example, Panda et al. 2012 
identified a chitohexaose residue from a filarial glycoprotein that hampers TLR4 activation 
by LPS and attenuates endotoxemia (Panda et al., 2012). Similarly, a Fasciola hepatica-
derived protein (FhDM-1) binds directly to LPS and thereby inhibits interaction with LBP 
(lipopolysaccharide binding protein) leading to reduced pro-inflammatory cytokine 
production (Robinson et al., 2011).  
These molecules directly inhibit LPS sensing by its receptor. More complex mechanisms 
that improve endotoxemia and sepsis involve the modulation of intracellular TLR signaling 
and other protective features like inhibition of coagulation. ES-62 a phosphorylcholine-
containing protein derived from A. vitae E/S products was demonstrated to induce hypo-
responsiveness to subsequent TLR-stimulation in a TLR4-dependent manner by 
degradation of MyD88 (Goodridge et al., 2005). As mentioned above, cystatins are a class 
of cysteine-protease inhibitors (CPI) that can be found in E/S products of a range of 
nematodes (Pfaff et al., 2002; Sun et al., 2013). Cystatins reduce macrophage and dendritic 
cell responsiveness to TLR ligands and induce IL-10 secreting macrophages that reduce 
endotoxin induced inflammatory responses (Klotz et al., 2011; Schnoeller et al., 2008). 
Reduction of coagulation by Ancylostoma canium-derived recombinant nematode anti-
coagulant protein c2 (rNAPc2) through inhibition of factor VIIa was further shown to 
improve septic insult and was even tested in a human endotoxemia trial (de Pont et al., 
2004) 
 
1.3.5 Similarities of alternative macrophage activation and endotoxin tolerance  
Interesting findings suggest a similarity of IL-4-induced alternative macrophage activation 
and endotoxin tolerant macrophages. Homodimers of NFB p50 subunits were found to be 
essential in both settings and p50-deficiency inhibited both, attenuated cytokine 
production in response to secondary LPS stimulation (endotoxin tolerance) and protective 
immunity to parasites (AAM mediated immunity) (Porta et al., 2009). Another report 
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demonstrated that endotoxin tolerant cells secrete the AAM-associated chemokines CCL17 
and CCL22 (Pena et al., 2011). However, a more recent study argues against a close 
similarity between AAM and endotoxin tolerant macrophages as IL-4R-deficient mice, 
which lack AAM, develop endotoxin tolerance. Furthermore, AAM-associated cytokines are 
not necessarily upregulated in endotoxin tolerance (Rajaiah et al., 2013). Conversely, 
induction of AAM was proven to be MyD88-independent (Mylonas et al., 2013). Abundant 
data supports differential induction of gene transcription by IL-4 and LPS (El Chartouni and 
Rehli, 2010; Gordon and Martinez, 2010; Mosser and Edwards, 2008; Xue et al., 2014), 
however, induction of endotoxin tolerance may promote an AAM-related phenotype and 
skew macrophages to resolution- and wound healing-associated functions. 
 
1.4 Objectives of this thesis 
Helminths induce regulatory, anti-inflammatory immune responses and helminth-derived 
molecules have been shown to reduce lipopolysaccharide-induced inflammation. In this 
thesis it was investigated, whether chronic infection of mice with the filarial nematode L. 
sigmodontis also reduces exacerbated inflammation in acute, E. coli-induced sepsis. The 
impact on bacterial burdens and anti-bacterial functions of the innate immune system 
were to be analyzed. Theoretically, a regulatory immune setting may reduce the anti-
bacterial capacity of chronic L.s.-infected mice. Further, several cell populations as 
eosinophils and regulatory T cells expand during helminth infection, which potentially 
influence the response to E. coli-challenge. By the usage of eosinophil-deficient dblGATA- 
and Treg-depleted DEREG-mice it was investigated whether ablation of those nematode-
induced cell populations resulted in an altered outcome. Since macrophages and their 
functional behavior play pivotal roles in both, bacterial sepsis and helminth infection, a 
special focus was to investigate the contribution of macrophages. Filariae-induced AAM 
potentially impair phagocytosis leading to increased bacterial loads. On the other hand 
AAM may reduce the systemic cytokine storm, which could improve recruitment of 
monocytes and neutrophils to the site of bacterial infection, thus improving bacterial 
clearance and containment of infection. Mechanistically, it was therefore to be 
investigated whether IL-4 receptor-dependent AAM induction or, on the other hand, the 
development of Wolbachia- and TLR2-dependent endotoxin tolerant macrophages 
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mediates protective effects of L.s.-infection. To achieve this, L.s.-infected wildtype mice 
ablated of total phagocytes by Clodronate liposomes, IL-4R/IL-5 double deficient, IL-4-/- 
and TLR2-/- mice were compared to naïve controls in the sepsis model. TLR2-dependent 
induction of tolerance by pre-stimulation with Wolbachia was investigated in vitro and in 
vivo and macrophages were analyzed for their activation status and anti-bacterial 
functions. Finally, to clarify the role of Wolbachia-derived stimuli on protective 
macrophage functions on the systemic level, macrophages from Wolbachia-treated cell 
cultures were adoptively transferred into mice before E. coli injection. Similarly, 
macrophages isolated from chronic L.s.-infected BALB/c wildtype and TLR2-/- mice were 
transferred to naïve recipients, which were subsequently challenged with E. coli. 
This thesis was performed in order to provide mechanistic insight to the complex interplay 
of concurrent chronic filarial infection and acute bacterial infection. Results from this thesis 
should contribute to a better understanding of filariae-induced immunomodulation and 
may reveal alternative treatment strategies for bacterial sepsis.  
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2 Material & Methods 
2.1 Supervision and team contributions 
As the group leader, principal investigator and mentor, Dr. Marc Hübner was responsible 
for the original idea, funding acquisition (BONFOR, DFG) and general supervising of 
experimental designs, data analyses and manuscript preparation. 
Experiments were performed with the technical help of Anna-Lena Neumann 
(technican/BA-student), Dominique Blömcker (diploma student), Constanze Kühn (master 
student), David Schmidt (technican), Afiat Berbudi, MD (PhD student), Jesuthas Ajendra 
(diploma/PhD student) and Benedikt Buerfent (diploma/PhD student). 
 
2.2 Material 
2.2.1 Laboratory equipment, machines and devices 
Centrifuge for 15ml, 50ml tubes and plates: Eppendorf 5810R, Eppendorf, Hamburg, 
Germany 
Centrifuge for 1.5ml caps, uncooled: Eppendorf 5424, Eppendorf, Hamburg, Germany  
Centrifuge for 1.5ml caps, cooled: Eppendorf 5417R, Eppendorf, Hamburg, Germany 
Centrifuge for quick spin: Labnet, Edison, USA 
Incubator, Memmert, Schwabach, Germany 
Water bath, Memmert, Schwabach, Germany 
Laminar flow bench: Mars safety class 2, Scanlaf, Labogene, Lynge, Denmark 
Cell culture pump: ILMvac, Ilmenau, Germany 
Desalted and sterile water generator: Direct Q 3UV, Merck, Darmstadt, Germany 
Gel-electrophoresis chambers: OWL Easycat B1, Thermo scientific, Waltham, USA 
Electrophoresis power supply: Consort EV243, Turnhout, Belgium 
UV gel documentation: UVsolo, Biometra, Göttingen, Germany 
DNA/RNA concentration: nanoVue, GE healthcare, Chalfont St Giles, GB 
RNA quality: Experion, BioRad, Hercules, USA 
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Pipettors/pipet-boys: OMEGA, Argos-tec, South Scottsdale Court, Ireland 
Pipettors/pipet-boys: INTEGRA biosciences, Konstanz, Germany 
Pipetts: Eppendorf, Hamburg, Germany 
Vortex Genie 2, Scientific Industries, New York, USA 
Laboratory balance: Kern und Sohn, Balingen, Germany 
ELISA reader SoftMax 340, Molecular Devices, Sunnyvale, USA 
Magnet stirrer: Yellow line MSHbasic, IKA, Staufen, Germany 
Lab shaker for plates: VWR, Radnor, USA 
PCR cycler: Tpersonal, Biometra, Göttingen, Germany 
Pipet robot: QIAgility, Qiagen, Hilden 
Sample preparation robot: QIAcube, Qiagen, Hilden 
RT-PCR cycler: RotorGene Q, Qiagen, Hilden 
Cell separation: LS-, LD-columns, manual separator, Miltenyi, Bergisch Gladbach, Germany 
Heating block/shaker for tubes: Thermomixer comfort, Eppendorf, Hamburg, Germany 
Fridge (4° C): Bosch, Stuttgart, Germany 
Freezer (-20° C): Liebknecht, Biberach, Germany 
Freezer (-80° C): New Brunswick scientific, Nijmegen, NL 
Bunsen burner: VWR, Radnor, USA 
 
2.2.2 Consumables 
Standard laboratory plastic consumables (tubes, caps, pipets, tips, cell culture plates, etc.) 
were from Sarstedt (Nümbrecht, Germany) Eppendorf (Hamburg, Germany) Greiner 
BioOne (Frickenhausen, Germany) and VWR (Radnor, USA) 
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2.2.3 Software 
BD FACSDiva , Becton Dickinson, Franklin Lakes, USA 
Softmax pro, Molecular devices, Sunnyvale, USA 
FlowJo, Ashland, USA 
Microsoft Office 2010, Microsoft Corporation, Albuquerque, USA 
Prism 5, Graphpad, San Diego, USA 
Gimp, www.gimp.org 
Mendeley Desktop, www.mendeley.com 
PubMed, http://www.ncbi.nlm.nih.gov/pubmed/ 
RT2 profiler PCR data analysis version 3.5, Qiagen, Hilden 
 
2.2.4 Institute’s facilities 
Incubator room (37° C) 
Cold room (4° C) 
Growth media facility (Dr. Lepin and Mr. Bergmann; LB agar plates, broth and antibiotics) 
Animal facility: Specified pathogen-free conditions, individually ventilated cages, food and 
water ad libitum. 
Parasite mouse containers: special facility for maintenance of parasites cycles and infection 
of experimental animals with individually ventilated cages, food and water ad libitum. 
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2.3 Methods and procedures 
2.3.1 Mice and parasites 
Animal housing conditions and the procedures used in this work were performed according 
to the European Union animal welfare guidelines. All protocols were approved by the 
Landesamt für Natur, Umwelt und Verbraucherschutz, Cologne, Germany (AZ 87-
51.04.2010.A066 and 84-02.04.2011.A326). 
All wildtype BALB/c mice were purchased from Janvier Labs, Saint-Berthevin, France. Gene 
deficient BALB/c mice were kindly provided by Prof. Dr. Klaus Matthaei, Australia National 
University College of Medicine, Biology and Environment, Canberra, Australia, (IL-4R/IL-5-
/- mice)(Kopf et al., 1996; Mohrs et al., 1999), Prof. Dr. Frank Brombacher, International 
Centre for Genetic Engineering and Biotechnology, Cape Town, South Africa (IL-4-/- 
mice)(Mohrs et al., 1999), Prof. Dr. Bernhard Ryffel, CNRS University of Orléans, France 
(TLR2-/- and TLR4-/- mice) (Hoshino et al., 1999; Takeuchi et al., 1999), Prof. Dr. Tim 
Sparwasser,  (DEREG) (Lahl et al., 2007) or purchased from Jackson Laboratories 
(dblGATA) (Yu et al., 2002). Mice were bred at the central animal facility of the University 
Hospital Bonn (HET) or at the local animal facility of the Institute of Medical Microbiology, 
Immunology and Parasitology, University Hospital Bonn. Mice were kept in individually 
ventilated cages with access to food and water ad libitum. 
Six to eight week old, female BALB/c, TLR2-/-, IL-4R/IL-5-/-, IL-4-/-, dblGATA and DEREG 
mice were infected with L. sigmodontis by natural infection as described before (Volkmann 
et al., 2003b). Ninety days post infection, a timepoint of chronic infection, experiments 
were performed. After euthanasia with Isoflurane, infection of mice was confirmed by 
screening for adult worms in the pleural cavity and microfilariae in the peripheral blood. 
 
2.3.2 Sepsis induction 
For sepsis induction, mice were i.p. injected with 2-20 x107 cfu of E. coli (ATTC 25922). Body 
temperature was determined hourly by infra-red measurement for a total of six hours. Six 
hours after injection, mice were euthanized and blood and peritoneal lavage were taken 
for ELISA and flow cytometric analysis as well as determination of cfu. For non-septic 
controls 200µl of sterile LB broth was injected. For sepsis survival experiments, 0.5-1x109 
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cfu were injected and mice were monitored for signs of convulsion, paralysis and low body 
temperature (<27°C). Mice showing these severe symptoms do not survive the sepsis and 
were therefore euthanized according to humane endpoint criteria.  
 
2.3.3 Determination of cytokine, chemokine and nitrite concentrations and cfu 
Six hours after E. coli challenge, mice were euthanized and the peritoneum of mice were 
lavaged with 5ml of cold PBS (PAA, Cölbe, Germany). Following centrifugation of the 
lavage, the supernatant was stored at -20°C for subsequent cytokine, chemokine and 
nitrite measurements. Part of the peritoneal lavage was plated in serial dilutions on LB agar 
plates and incubated over night at 37°C to determine the cfu. Peritoneal cells were 
prepared for subsequent analysis as described below.  
To determine cytokine and chemokine concentrations in serum, peritoneal lavage and cell 
culture supernatants, ELISAs were performed in duplicate wells according to kit protocols 
(TNFα, IL-1β: eBioscience, San Diego, USA; IL-6, IL-10: BD Biosciences, San Diego, USA; MIP-
2β , KC/CXCL1 and IL-5: R&D systems, Minneapolis, USA). To determine nitrite 
concentrations in supernatants, the Griess reagent assay was performed according to the 
kit protocol (Thermo Fisher Scientific, Waltham, USA). Data was acquired using a 
microplate reader and Softmax Pro software (both Molecular Devices, Sunnyvale, USA). 
 
2.3.4 Flow cytometry 
For flow cytometric analysis, cells were fixed in fixation/permeabilization buffer 
(eBioscience) over night, washed and blocked in PBS containing 1% bovine serum albumin 
(BSA, fraction V, PAA, Linz, Austria) and rat immunoglobulin (1µg/ml, Sigma, St. Louis, USA). 
Cells were stained with F4/80 APC, F4/80 PerCP-Cy5.5, CD11b APC, CD11b FITC, Gr1 PE-
Cy7, CD80 FITC, CD86 PE, CD86 APC, MHC2 PE, MHC-II FITC, CD40 PE (all eBioscience) and 
SiglecF PE (BD Biosciences). To stain for AAM, cells were pre-incubated in permeabilization 
buffer (eBioscience) for 20 minutes and then stained with anti-RELMα (Peprotech, New 
Jersey, USA). Subsequently, cells were washed twice in permeabilization buffer and a 
secondary antibody (goat anti-rabbit Alexa488, Invitrogen, Carlsbad, USA) was used. As a 
control unspecific and isotope-matched Alexa488 antibody (Invitrogen) was used. Data was 
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acquired using a BD FACS Canto and BD FACSDiva software; for generation of figures and 
plots FlowJo software (Tree Star, Ashland, USA) was used. 
 
2.3.5 Macrophage depletion with Clodronate liposomes 
Clodronate containing liposomes and PBS containing liposomes as a negative control were 
kindly provided by N. Van Rooijen (Clodronate Liposomes Foundation, The Netherlands; 
clodronate.liposomes.com) and used in our experiments to deplete macrophages in vivo 
(Biewenga et al., 1995) from helminth infected mice and controls prior to sepsis induction. 
Therefore, mice were i.p. injected with 100µl of sterile liposome suspension three and one 
day before the mice were challenged i.p. with E. coli. Successful depletion of macrophages 
was confirmed by flow cytometric analyses of the peritoneal lavage and peripheral blood. 
 
2.3.6 Macrophage elicitation and stimulation 
Thioglycollate elicited macrophages were isolated by peritoneal lavage four days after 
naïve BALB/c mice were i.p. injected with sterile thioglycollate broth. Equal numbers of 
peritoneal cells were allowed to adhere to cell culture dishes for two hours. After that, 
non-adhered cells were removed and adherent cells were washed twice resulting in a 
macrophage purity based on F4/80 expression of >95%. Macrophages were cultured in 
RPMI 1640 containing 10% fetal calf serum (heat inactivated), 1% Penicillin/Streptomycin 
and 1% L-Glutamine (all from PAA) and stimulated for a total of 18h. For stimulation LPS 
ultrapure (300ng/ml), Pam3CSK4 (P3C, 100ng/ml), FSL-1 (100ng/ml) were used (all 
Invivogen, San Diego, USA). L. sigmodontis adult worm extract (LsAg) and L. sigmodontis 
adult worm extract from Wolbachia-depleted adult worms (Ls-tet) were prepared as 
previously described (Volkmann et al., 2003; Ziewer et al., 2012) and used at a 
concentration of 25µg/ml for stimulation. Extracts from the insect cell line C6/36 were 
used at a concentration of 6µg/ml for both control and Wolbachia infected insect cells. For 
re-stimulation experiments, cells were initially stimulated for 18h as described above, then 
washed twice and re-stimulated using LPS ultrapure (300ng/ml) or medium for an 
additional 18 hours. Subsequently, supernatants were collected for cytokine/chemokine 
determination; cells were washed and detached with a cell scraper, blocked and stained for 
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flow cytometric analyses. LsAg was tested for endotoxin (LPS)-contamination in the Limulus 
amebocyte lysate (LAL) test (QCL-1000 Test, Lonza, Cologne, Germany), revealing a LPS 
concentration of 18 pg/ml or 0.18 EU/ml (final endotoxin concentration in culture: 0.45 
pg/ml). 
 
2.3.7 Gentamycin assay for in vivo phagocytosis assessment 
2x107 cfu E. coli (ATTC 25922) were injected i.p. into chronic L. sigmodontis-infected BALB/c 
mice and naïve controls. Three hours after inoculation, mice were killed and cells were 
obtained by peritoneal lavage. Equal numbers of macrophages were allowed to adhere to 
cell culture dishes for two hours at 37°C in RPMI 1640 medium containing gentamycin 
(100µg/ml, PAA). Non-adherent cells were removed and adherent cells were cultured for 
an additional four hours in gentamycin medium (100µg/ml). Subsequently, adherent 
macrophages were lysed in 1% Triton-X100 and lysates were plated on LB agar plates and 
incubated overnight. Colonies were enumerated the following day. 
 
2.3.8 Phagocytosis of pHrodoTM-E. coli BioParticles®  
Chronic L. sigmodontis-infected mice and uninfected controls were i.p. injected with 100µg 
of pHrodoTM-E. coli BioParticles® from Thermo Scientific. At 90 min and 6h post injection, 
mice were euthanized and peritoneal lavage was analyzed by flow cytometry to assess the 
frequencies of pHrodo positive macrophages. 
 
2.3.9 Macrophage gene expression analysis  
Three hours after i.p. E. coli injection mice were euthanized and peritoneal cells were 
obtained. Additional controls included peritoneal cells from L. sigmodontis-infected and 
naïve mice in the absence of an E. coli challenge. Peritoneal cells were washed in PBS and 
incubated in supplemented RPMI 1640 for one hour for separation by adhesion. Non-
adherent cells were removed and adherent cells were stained with F4/80-biotin after 
blocking in PBS containing 1% BSA and rat Ig (1µg/ml). F4/80 positive macrophages were 
further purified by magnetic separation using Streptavidin coated magnetic beads (MACS, 
Miltenyi Biotech, Bergisch-Gladbach, Germany) resulting in an average purity of >95%. 
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RNA was isolated from purified macrophages using Trizol extraction (Ambion, Austin, USA) 
and RNeasy Plus Mini Kit (Qiagen, Hilden, Germany). RNA was quantified by NanoVue (GE 
Lifescience, Chalfont St Giles, Great Britain) and quality was assessed using the Experion gel 
electrophoresis system (BioRad, Hercules, USA). cDNA was synthesized with the RT2 first 
strand kit (Qiagen). A customized RT2 PCR array (Qiagen) was performed on cDNA using a 
Rotor Gene Q (Qiagen). The complete list of genes included in this array is reported in table 
S1. Three biological replicates per group were performed. Data was processed and 
displayed using the online RT2 Profiler PCR Array Data analysis 3.5 software at the 
sabiociences.com website (Qiagen). Gene expression was normalized to 5 housekeeping 
genes (Actb, B2m, Gapdh, Gusb, Hsp90ab1). Genes are only reported with p<0.05 and >2-
fold change. 
 
2.3.10 Isolation of eosinophils and eosinophil transfer 
Cells of the pleural cavity of L.s. infected BALB/c mice (d90pi) were lavaged with cold PBS. 
Cells were washed twice and cells were incubated with anti-CD90.2, anti-B220 and anti-
MHC-II magnetic beads from Miltenyi Biotech (Bergisch Gladbach, Germany) for 15 
minutes on ice. Subsequently the solution was run through a LD collum (Miltenyi). The flow 
through was collected and incubated in fully complemented medium (RPMI) for 15 minutes 
in a cell culture dish for adhesion of unwanted cells. Purity of the gained cells was 
determined by flow cytometric analysis and was >90%. Six uninfected dblGATA mice 
received purified eosinophils from 12 donor mice (ratio: 2donors per recipient). Ninety 
minutes after the eosinophil transfer sepsis was induced by i.p. E. coli injection.   
 
2.3.11 Depletion of regulatory T cells from DEREG mice 
DEREG (foxp3-GFP-DTR knock-in) mice on the BALB/c background and BALB/c controls 
were naturally infected with L. sigmodontis and sepsis experiments were conducted at day 
90 post infection. Two and one day before the E. coli injection, DEREG and BALB/c control 
mice were injected i.p. with 200µl of Diphteria Toxin. Depletion of Foxp3-positive cells was 
confirmed by gating on CD4- and CD25-positive cells, expressing eGFP in flow cytometric 
analyses of splenocytes. 
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2.3.12 In vitro TLR2 blocking 
For blocking experiments, cells were pre-incubated with 20 µg/ml anti-mouse TLR2 (T2.5) 
or isotype-matched rat IgG (eBioscience) for 1.5 h prior stimulation. 
 
2.3.13 Nematode excretory/secretory products 
Native L. sigmodontis ALT-1 and CPI-2 protein were kindly provided by S. Babayan 
(University of Glasgow, Glasgow, UK), recombinantly expressed in E. coli. 
Acanthocheilonema viteae ES-62 was kindly supplied by W. Harnett (University of 
Strathclyde, Glasgow, UK) in non-frozen aqueous solution. For injection 2µg of the 
respective compounds were administered i.p. in a total volume of 100µl 24 hours before E. 
coli challenge. 
 
2.3.14 In vivo depletion of neutrophils 
Neutrophils were depleted by two i.p. injections of anti-Ly6G antibody (50µg, clone: 1A8, 
BioXcell, West Lebanon, NH, USA) one day as well as one hour before induction of sepsis. 
 
2.3.15 Statistics 
GraphPad Prism software Version 5.03 (GraphPad Software, San Diego, USA) was used for 
statistical analysis. Mann-Whitney-U-test tested differences between two unpaired groups 
for statistical significance. Differences between multiple groups were tested for statistical 
significance using the Kruskal–Wallis test, followed by Dunn post hoc test. P-values of <0.05 
were considered statistically significant.   
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3 Results 
3.1 Chronic Litomosoides sigmodontis infections in susceptible BALB/c 
mice 
3.1.1 Parasitemia in BALB/c mice at the chronic stage of Litomosoides 
sigmodontis infection 
In susceptible BALB/c mice the chronic stage of Litomosoides sigmodontis (L.s.) infection 
(here day 90 p.i.) is not associated with prominent pathology. Infected mice don’t show any 
signs of illness or compromised behavior. Adult worms reside in the pleural cavity and 
become encapsuled in granulomata to varying extents over time. In the current study adult 
worms and granuloma formation was recorded only qualitatively. Mice with no worms in 
the pleural cavity present were regarded as uninfected and therefore excluded from the 
experiment. The transmissive stage of L. sigmodontis, the microfilariae (mf) were counted 
in 30µl of peripheral blood after red blood cell lysis. In a total of 15 experiments analyzed 
the frequency of microfilariae-positive (mf+) animals ranged from 0 to 100% with a median 
of 66.6% mf+ animals (mf+ = at least one mf in 30µl blood) (Fig. 1A). The absolute mf load 
per mouse in the fifteen experiments analyzed normally ranged from 0-10 mf per 30µl 
blood (Fig. 1B). When all animals were pooled, a median number of 2 mf per 30µl blood 
was calculated from 139 BALB/c mice at day 90 post infection (Fig. 1C). In the pooled data 
82 of 139 mice were mf+, which equals 59% mf+ animals (Fig. 1C).  
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Figure 1: Frequencies of mf+ mice and total numbers of microfilariae in chronic L. sigmodontis-
infected BALB/c mice 90 dpi. 
Frequency of mf+ L. sigmodontis-infected mice per experiment (A). Microfilariae count per animal 
in 30µl blood of 15 individual experiments (B). Pooled mf-data of 139 BALB/c mice 90 days post 
infection (C). Red lines represent median. 
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3.1.2 Parasitemia and pathology in chronic L. sigmodontis-infected TLR2-/-, IL-4-/- 
and IL-4R/IL-5-/- mice 
Parasite burden (Mf count and adult worm numbers) was not altered in TLR2-deficient 
mice 90 dpi (Fig. 2A and not shown), suggesting no direct effects of TLR2-deficiency on 
parasite survival and development at that timepoint. On the other hand IL-4-/- and IL-
4R/IL-5-/- mice had significantly more adult worms and mf. Mice from both knock-out 
strains had significantly more mf per 30µl blood than infected WT BALB/c controls (Fig. 2B, 
C). This suggests that IL-4/IL-4R dependent signaling contributes to parasite control.  
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 2: Lack of IL-4 and IL-4R, but not TLR2, leads to increased mf loads in chronic L. 
sigmodontis-infected mice. 
Mf in 30µl blood of TLR2-/- (A), IL-4-/- (B) and IL4Ra/IL-5-/- mice and wildtype BALB/c controls 90 dpi. 
Pooled data from two independent experiments are shown (A, C). Red lines represent median. 
Data was tested for statistical significance by non-parametric Mann-Whitney U test. ns: p>0.05; ** 
p<0.01; *** p<0.001 
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Chronic L.s. infection led to enlarged spleens in host BALB/c mice. Interestingly, in IL-
4R/IL-5-/- mice spleens were further enlarged (splenomegaly) (Fig. 3). This may be due to 
the high microfilariae counts in the bloodstream of IL-4R/IL-5-/- mice.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 3: Splenomegaly in L. sigmodontis infected IL-4R/IL-5 double deficient mice. 
Shown spleens were taken 90 days post L. sigmodontis infection from BALB/c (II) and IL-
4R/IL-5-/- mice (IV) as well as naive BALB/c (I) and naive IL-4R/IL-5-/- controls (III). Black 
scale bar represents 1 cm. 
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3.1.3 Cellular and humoral changes in chronic L. sigmodontis-infected BALB/c 
mice  
3.1.3.1 Cellular changes at the site of infection, the pleural cavity 
The most prominent changes induced by chronic L.s. infection occur within the pleural 
cavity, where the adult worms reside. 90 day post L.s. infection, frequencies (Fig 4A, B) and 
total numbers (data not shown) of eosinophils (SiglecF+) and neutrophils (Gr1+) were 
significantly increased compared to uninfected controls. AAM were strongly induced by L.s. 
infection as was observed by increased RELM (Resistin-like molecule alpha) expression 
levels (Fig. 4C). Accordingly, frequency of F4/80 and RELMdouble positive AAM was 
significantly higher in L.s-infected mice (Fig. 4D). 
 
 
 
 
 
Figure 4: Granulocytes and AAM are abundant in the pleural cavity during L.s.-infection. 
Frequency of SiglecF+ eosinophils (A) and Gr1+ neutrophils (B), RELM expression of F4/80+ 
macrophages (C) and frequencies of F4/80+, RELM+ AAM (D) in the pleural cavity of L.s.-
infected mice at day 90 post infection. Data is depicted as mean +/- SEM and was tested for 
statistical significance by Mann-Whitney U test. n>6 per group. ***p<0.001; **p<0.01 
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Systemic serum cytokine/chemokine levels from L.s.-infected mice were analyzed by ELISA. 
No pro-inflammatory cytokines/chemokines (e.g. IL-6, TNF, MIP-2) were detectable in 
BALB/c mice at the chronic stage of infection (day 90 p.i.). Similarly, Th2 associated 
cytokines like IL-4 and IL-13 as well as suppressive IL-10 was not detectable (data not 
shown). However, the eosinophil-associated mediators IL-5 and Eotaxin-1 (CCL11) were 
significantly increased in serum of chronic L.s.-infected mice (Fig. 5A, B), demonstrating the 
contribution of eosinophils to the immune-response to L.s.-infection. Similarly, serum 
levels of TGF and monocyte-chemoattractant protein 2 (MCP-2, CCL8) were significantly 
higher in L.s.-infected mice, compared to naïve controls (Fig. 5C, D).   
 
 
 
 
 
Figure 5: Concentrations of IL-5, Eotaxin-1, TGF and MCP-2 are increased in serum of chronic 
L.s.-infected BALB/c mice. 
IL-5 (A), Eotaxin-1 (CCL11) (B), TGF (C) and MCP-2 (CCL8) (D) levels measured in chronic L.s.-
infected (d90pi) and uninfected control mice. Data is depicted as mean+/- SEM and was tested for 
statistical significance by Mann-Whitney U test. n>5 per group. ***p<0.001; **p<0.01; *p<0.05 
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3.1.3.2 L. sigmodontis infection induces L. sigmodontis- and Wolbachia-specific 
antibodies 
In response to L.s. infection antibodies of several isotypes are produced. 90 dpi titers of 
LsAg-specific antibodies of the Isotypes IgG1, IgG2a/b and IgE were significantly increased 
compared to naïve animals (Fig. 6A). Wolbachia-specific IgG1 antibody titers in the serum 
of infected animals rose over time and remained elevated throughout patent infection (Fig. 
6B). Interestingly, the levels of anti-Wolbachia IgG1 peaked at day 51 post infection and 
thus correlated with the onset of microfilaremia. The presence of Wolbachia-specific 
antibodies suggests that endosymbiotic Wolbachia are accessed by the murine immune 
system and an immune response is mounted. Importantly, both, TLR2- (Fig. 6C) and IL-
4R/IL-5-deficient mice (Fig. 6D) were able to mount an antibody response to L.s. infection. 
No differences in LsAg-specific IgG1 were detected between chronically infected TLR2- and 
IL-4R/IL-5 deficient mice and infected wildtype BALB/c controls at day 90 post infection.  
 
 
 
 
 
 
Figure 6: LsAg- and Wolbachia-specific antibodies are produced in chronic L. sigmodontis-infected 
mice 
L. sigmodontis antigen (LsAg)-specific serum IgG1, IgG2a/b and IgE levels in L.s.-infected (red) and 
naive (black) animals (A). Kinetics of Wolbachia-specific IgG1 levels in L.s.-infected BALB/c mice over 
the timecourse of 141 days post L.s. infection (B). LsAg-specific IgG1 from BALB/c and TLR2-/- (C) or 
IL-4R/IL-5-/- (D) mice at day 90 post infection and respective naive controls. Differences were tested 
for statistical significance by Mann-Whitney U test (A) or Kruskal-Wallis non-parametric 1-way 
ANOVA followed by Dunn‘s post hoc test (C, D). n≥4 per group.  ***p<0.001; **p<0.01; *p<0.05; ns 
p>0.05 
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3.2 L. sigmodontis-E. coli co-infection and experimental manipulations of the in 
vivo model 
3.2.1 Chronic Litomosoides sigmodontis- infection improves Escherichia coli-
induced sepsis 
In order to investigate the impact of L. sigmodontis-induced immunomodulation on the 
systemic inflammatory response to bacteria chronic L. sigmodontis-infected mice (day 90 
post infection) were challenged intra-peritoneally with E. coli. For the duration of six hours, 
mice were monitored for the development of hypothermia. After six hours mice were 
euthanized and levels of pro-inflammatory cytokines and chemokines were determined in 
the serum and locally at the site of E. coli injection (the peritoneum). The peritoneal lavage 
was further analyzed for bacterial burden and for cell populations present. Markers of 
macrophage activation (e.g. CD86) and AAM phenotype (i.e. RELM) were determined to 
gain insights into the cellular mechanisms leading to an altered sepsis response.  
Abnormal body temperature like hypothermia and fever are physiological symptoms of 
sepsis. Non-L.s.-infected BALB/c mice challenged with E. coli incrementally lost body 
temperature over time, whereas mice chronically infected with L.s. regained their original 
body temperature after six hours (Fig. 7A). L. sigmodontis-infected mice had significantly 
lower bacterial loads in their peritonea 6h after E. coli challenge, suggesting an improved 
bacterial killing in L.s.-infected mice (Fig. 7B). In order to analyze time kinetics, bacterial 
burden in the peritoneal cavity was analyzed 1, 3 and 6h after E. coli challenge. As soon as 
three hours after E. coli injection, L. sigmodontis-infected mice had a significantly reduced 
peritoneal bacterial burden. Systemic mediators of inflammation like IL-6, TNFILβ and 
MIP-2 were strongly induced by E. coli challenge, while L.s.-infected mice had significantly 
lower serum concentrations of those mediators as compared to E. coli-only challenged 
controls (Fig. 7C). None of these inflammatory mediators were detectable in non-E. coli 
challenged mice, regardless of L.s. infection and are therefore not shown. Exceptions were 
serum IL-5 and TGF levels, which were elevated by L.s. infection and further increased by 
E. coli challenge (Fig. 7D). 
The peritoneal lavage taken from mice six hours after E. coli injection contained resident 
and recruited cells. Neutrophils were strongly recruited to the site of E. coli injection in 
mice from both groups. Chronic L.s.-infected mice had significantly more neutrophils in the 
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peritoneum six hours after E. coli injection, compared to uninfected controls (Fig. 8A). 
Further flow cytometric analyses showed that numbers of F4/80-positive macrophages in 
the peritoneum decreased in response to E. coli injection in both groups. Nevertheless, six 
hours after E. coli challenge L.s.-infected mice had significantly higher macrophage 
numbers than uninfected control mice (Fig. 8B). Frequencies of AnnexinV+ and propidium 
iodide+ macrophages were significantly lower in L.s.-infected mice, demonstrating that 
macrophages derived from L.s.-infected mice were less prone to apoptosis than 
macrophages of E. coli-only treated mice (Fig. 8C). Expression of CD80 and CD86 was lower 
in L.s.-infected mice suggesting reduced macrophage activation, further demonstrating the 
attenuated immune response in L.s.-infected mice (Fig. 8D). Interestingly, RELM, a marker 
for IL-4 receptor alpha (IL-4Rα)-induced AAM, was induced in peritoneal macrophages of 
L.s.-infected mice following E. coli challenge, although without E. coli challenge, RELM 
expression in L.s-infected animals was restricted to pleural macrophages (the site of L.s. 
adult worms) and not present on peritoneal macrophages (Fig. 8D). In a separate 
experiment, mice received a lethal dose of E. coli intra-peritoneally and survival was 
monitored according to humane endpoint criteria. This experiment demonstrated a 
substantial survival benefit for chronic L.s.-infected mice in E. coli-induced sepsis (Fig. 9). All 
eight mice of the L.s.-uninfected group died within the first 12 hours after E. coli challenge, 
whereas only 3 out of 8 chronic L.s.-infected mice died during that period (Fig. 9). After one 
week 50% (4 out of 4 mice) of the L.s. group were still alive.  
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Figure 7: Chronic L. sigmodontis infection improves sepsis-associated hypothermia, bacterial 
loads and systemic cytokine storm. 
(A) Kinetics of body temperature in response to i.p. E. coli injection of uninfected (n=17) and 
chronic L. sigmodontis (L.s.)-infected mice (n=19). (B) Peritoneal bacterial load (cfu, colony 
forming units) at 1, 3 and 6 hours after E. coli injection. (C) Serum cytokine/chemokine 
concentrations (n=5-6/group) of uninfected and L. sigmodontis-infected mice six hours post E. coli 
injection as well as serum (D) IL-5 and TGF levels of L.s.-infected and uninfected mice six hours 
after E. coli or mock treatment (sterile LB broth). (A) shows pooled data from two independent 
experiments and (B-D) show one representative dataset of three independent experiments. Data 
in (A) is displayed as mean +/- SEM and was tested for statistical significance by 2-way ANOVA 
and Bonferroni post hoc test; data in (B and C) is shown as median and was tested for statistical 
significance by Mann-Whitney-U-test. In (D) data is presented as median and was tested for 
statistical significance by 1-way ANOVA followed by Dunn’s post-hoc test. (*p<0.05, **p<0.01, 
***p<0.001) 
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Figure 8: Chronic L. sigmodontis infection reduces E. coli-induced macrophage activation 
and apoptosis. 
(A) total number of peritoneal Gr1+ neutrophils and (B) F4/80hiCD11bhi macrophages six 
hours post injection of E. coli or sterile LB broth (indicated as mock; n=4-6/group). (C) 
Frequencies of PI-positive (dead), Annexin V-positive (apoptotic) and double negative (live) 
F4/80+ macrophages three hours post E. coli challenge. (D) CD80, CD86 and RELMα 
expression (as mean fluorescence intensity) of F4/80hi macrophages (n=4/group) six hours 
post E. coli injection; shown data in (A-D) represents one of three independent 
experiments. Data in (A-D) is shown as median and was tested for statistical significance by 
Mann-Whitney-U-test (*p<0.05, **p<0.01, ***p<0.001). 
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Figure 9: Chronic L. sigmodontis infection improves survival of E. coli-induced sepsis. 
Survival of naïve and L. sigmodontis-infected mice after i.p. injection with 6 x 108 cfu E. 
coli (n=8/group). After E. coli injection mice were monitored for signs of drop-out 
criteria according to “humane-endpoint” criteria. Data was tested for statistical 
significance by Mantel-Cox Log-rank test (**p= 0.0016).  
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3.2.2 Macrophages contribute to the protective effect of L.s. infection on E. coli-
induced sepsis 
Above mentioned experiments revealed that macrophages were modulated in L.s.-infected 
and E. coli challenged mice. A lower frequency of macrophages from L.s.-infected mice 
underwent apoptosis, potentially contributing to the observed higher macrophage 
numbers six hours after E. coli challenge. Furthermore, macrophages from L.s.-infected 
mice expressed lower levels of co-stimulatory CD80 and CD86, and a larger proportion was 
RELM –positive. 
In order to investigate if macrophages play an essential role in the L.s.-mediated protective 
effect on sepsis, macrophages were depleted in vivo using Clodronate-Liposome injections 
three and one day before E. coli challenge.  
Macrophage depletion prevented the L.s.-mediated protective effect on sepsis. Naïve and 
L.s.-infected animals developed a more severe hypothermia when injected with Clodronate 
liposomes (Fig. 10A). Furthermore, improvement of bacterial clearance in L.s.-infected mice 
was impaired by macrophage depletion (Fig. 10B). Serum levels of E. coli-induced pro-
inflammatory TNF and MIP-2 were also significantly increased in macrophage depleted 
L.s.-infected mice (Fig. 10C), when compared to L.s.-infected mice that received PBS-
containing liposomes. Of note, injection of Clodronate liposomes alone did not induce 
detectable amounts of pro-inflammatory cytokines in the serum (data not shown). 
Interestingly, macrophage depletion did not affect bacterial clearance and 
cytokine/chemokine concentrations in serum of E. coli-only treated mice, but significantly 
reduced body temperature 5 and 6 hours after E. coli challenge. This suggests that in L.s.-
infected animals macrophages mediate a beneficial effect on bacterial clearance and 
systemic inflammation that is not present in E. coli-only challenged mice.   
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Figure 10: Macrophage depletion renders L. sigmodontis-infected mice susceptible to E. coli-
induced sepsis 
Chronic L. sigmodontis (L.s.)-infected BALB/c mice and uninfected controls (U) were i.p. injected 
with Clodronate- (Clod.) or PBS-containing (PBS) liposomes before E. coli injection. (A) Kinetics of E. 
coli-induced hypothermia. (B) Peritoneal bacterial load and (C) serum TNFα and MIP-2β levels six 
hours after E. coli injection. (A) and (B) show pooled data from three independent experiments with 
at least 4 mice per group. (C) shows pooled data from two independent experiments. Data in (A) is 
displayed as mean +/- SEM and was tested for statistical significance by 2-way ANOVA and 
Bonferroni post-hoc test. Asterisks indicate statistical significant differences between L.s. + PBS and 
L.s. + Clod. treated groups, paragraphs indicate statistical significant differences between L.s. + PBS 
and U + PBS treated mice. In (B) and (C) data is presented as median and was tested for statistical 
significance by 1-way ANOVA followed by Dunn’s post-hoc test. *p<0.05, **p<0.01, ***p<0.001. 
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Importantly, although Clodronate liposome treatment effectively depleted peritoneal 
F4/80+ macrophages (fig. 11A), Clodronate did not significantly reduce peritoneal 
monocyte frequencies (Fig. 11B) or neutrophil numbers (Fig. 11C) in the peritoneum. 
The results of these experiments suggest that macrophages modulated by L.s. infection 
may be the essential cellular players mediating protection from exacerbated pro-
inflammatory responses in E. coli sepsis. 
 
 
 
 
 
 
  
Figure 11: Peritoneal macrophages, but not monocyte frequencies and neutrophil numbers are 
reduced following Clodronate-liposome treatment in E. coli-challenged mice. 
(A) Frequency of F4/80hi CD11bhi macrophages, (B) Ly6C+ F4/80neg monocytes and (C) total number 
of Gr1+ F4/80neg neutrophils in the peritoneum after PBS- (PBS) or Clodronate (Clod.) containing 
Liposome treatment and injection of E. coli. Graphs show data obtained six hours after E. coli 
challenge or mock treatment. Data is presented as median and was tested for statistical 
significance by 1-way ANOVA followed by Dunn’s multiple comparisons test.*p< 0.05; **p< 0.01; 
***p< 0.001. 
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3.2.3 Protection against E. coli-induced sepsis is not compromised in L. 
sigmodontis-infected IL-4R/IL-5-/- mice lacking AAMs 
In order to investigate the contribution of L.s.-induced AAM to the attenuated sepsis 
symptoms seen in L.s.-infected mice, chronic L.s.-infected wildtype BALB/c and IL-4R/IL-5-
/- mice were subjected to E. coli-induced sepsis and compared to non-L.s.-infected controls. 
Both, L.s.-infected wildtype BALB/c and AAM-deficient IL-4R/IL-5-/- mice displayed similar 
improved hypothermia (Fig. 12A) and peritoneal bacterial loads six hours post E. coli 
challenge (Fig. 12B). Accordingly, serum levels of TNF (Fig. 12C), IL-6 (Fig. 12D), and MIP-
 (Fig. 12E) were significantly reduced compared to uninfected controls and not altered 
compared to L.s.-infected wildtype BALB/c mice. Deficiency for RELM expressing AAM in 
L.s.-infected IL-4R/IL-5-/- mice was confirmed by flow cytometry (Fig. 13A, B). The gating 
strategy is given in figure 14. Interestingly, IL-4R/IL-5-/- mice did not only fail to induce 
RELM-positive macrophages in response to L.s. infection (Fig. 13A), but also had reduced 
peritoneal eosinophil frequencies compared to L.s.-infected BALB/c wildtype mice (Fig. 
13C). In contrast, neutrophil recruitment to the peritoneal cavity was comparable in L.s.-
infected IL-4R/IL-5-/- and WT mice after E. coli challenge (Fig. 13D). 
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Figure 12: L. sigmodontis-mediated protection against E. coli-induced sepsis is not 
compromised in AAM-deficient IL-4R/IL-5-/- mice. 
Kinetics of body temperature in response to i.p. E. coli injection of uninfected (U) and chronic 
L.s-infected wild type and IL-4R/IL-5 deficient mice (A). Peritoneal bacterial load (B), serum 
concentrations of TNFα (C), IL-6 (D) and MIP-2β (E). (A-E) shows a representative dataset from 
one of two independent experiments with at least 5 mice per group. Data shown in (A) is 
displayed as mean +/- SEM and was tested for statistical significance by 2-way ANOVA and 
Bonferroni post-hoc test (asterisks indicate statistical significant differences between L.s.-
infected and uninfected IL-4R/IL-5-/- mice and §-symbols between L.s.-infected and 
uninfected wild type mice). Data in (B-D) were tested for statistical significance by 1-way 
ANOVA followed by Dunn’s post-hoc test (*p<0.05, **p<0.01; ***p<0.001; ns p>0.05). 
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Figure 13: L. sigmodontis infected IL-4R/IL-5-/- mice lack AAM and have less eosinophils, while 
neutrophils remain unaffected 
Frequency of macrophages that express RELMα+ six hours after E. coli challenge (A). 
Representative histogram of RELMα fluorescence intensity of F4/80hi peritoneal macrophages 
(isotype control (shaded), L.s.-infected IL-4R/IL-5-/- mice (green), L.s.-infected BALB/c mice (red) 
six hours after E. coli challenge) (B). Numbers of SiglecF+ eosinophils (C) and Gr1+ neutrophils (D) 
in the peritonea of mice six hours post E. coli challenge. (A, C, D) show a representative dataset 
from one of two independent experiments with at least 5 mice per group. Data in (A, C, D) were 
tested for statistical significance by 1-way ANOVA followed by Dunn’s post-hoc test (*p<0.05, 
**p<0.01; ns p>0.05). 
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Figure 14: Gating strategy for alternatively activated macrophages 
Peritoneal cells were stained for F4/80 and RELM with specific antibodies. F4/80-positive 
cells were gated to obtain macrophage frequencies. (left); RELM-positive macrophages were 
assessed as percent of total F4/80+ macrophages (middle), or RELM mean fluorescence 
intensity (MFI) of all F4/80+ macrophages (right). Antibody specificity was controlled by 
isotype control antibody staining and FMO-approach (fluorescence minus one), (not shown). 
Upper row shows peritoneal cells from E. coli-only treated mice without L.s.-infection, lower 
row shows cells from co-infected (L.s.+E. coli) mice. 
3 Results 
 
46 
 
3.2.4 Chronic L. sigmodontis-infected IL-4-/- mice are protected against E. coli-
induced sepsis  
IL-4 and IL-13 bind the L-4Rα to induce AAM. In order to investigate the contribution of IL-4 
in the L.s.-mediated protective effect in E. coli sepsis, it was tested if chronic L.s.-infected 
IL-4-/- mice were protected from severe sepsis by L.s. infection. Similarly to the observed 
outcome in IL-4R/IL-5-/-, IL-4 deficiency had no impact on the beneficial effect of chronic 
L.s. infection on E. coli-induced sepsis. Five and six hours after E. coli challenge, chronic L.s.-
infected IL-4-/- mice had significantly higher body temperatures than uninfected IL-4-/- 
controls (Fig. 15A). Bacterial clearance from the peritoneum was also reduced compared to 
controls, although not significantly (Fig. 15B). No significant differences in body 
temperature (Fig. 15A), bacterial loads (Fig. 15B) and systemic MIP-2 and TNF levels (Fig. 
15C, D) six hours after E. coli challenge were detectable between chronic L.s.-infected 
BALB/c and IL-4-/- mice. Recruitment of eosinophils (Fig. 15E) and neutrophils (Fig. 15F) to 
the peritoneal cavity was similarly improved in L.s.-infected IL-4-/- and wildtype mice, when 
compared to uninfected controls. 
The outcome of these experiments suggests that IL-4/IL-4R induced AAM are not required 
for the beneficial effect of L.s. infection on E. coli-induced sepsis. 
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Figure 15: L. sigmodontis-mediated protection against E. coli-induced sepsis is not compromised 
in IL-4 deficient mice. 
Kinetic of body temperature in response to i.p. E. coli injection in uninfected (U) and chronic L. 
sigmodontis (L.s.)-infected wild type and IL-4-deficient BALB/c mice (A). Peritoneal bacterial load 
six hours post E. coli injection (B). Serum levels of MIP-2β (C) and TNFα (D) and peritoneal 
eosinophil- (E) and neutrophil- (F) numbers six hours after E. coli challenge. Data shown in (A) is 
displayed as mean +/- SEM and was tested for statistical significance by 2-way ANOVA and 
Bonferroni post-hoc test (asterisks indicate statistical significant differences between L.s.-infected 
and uninfected IL-4-/- mice and §-symbols between L.s.-infected and uninfected wild type mice. 
Data in (B-F) is presented as median and was tested for statistical significance by 1-way ANOVA 
followed by Dunn’s post-hoc test (*p<0.05; **p<0.01; ***p<0.001; ns p>0.05). 
3 Results 
 
48 
 
3.2.5 Eosinophils and eosinophil-deficient mice in L.s.-E. coli co-infection 
3.2.5.1 The protective effect of L.s. infection on E. coli-induced sepsis is impaired 
in eosinophil-deficient dblGATA mice  
Eosinophils are a hallmark of L.s. infection. In order to investigate the importance of 
eosinophils for the L.s.-mediated protection against severe sepsis symptoms, eosinophil-
deficient dblGATA mice were used in sepsis experiments. Chronic L.s.-infected dblGATA 
mice were challenged with E. coli and body temperature was monitored over the time 
course of six hours. At 5 and 6 hours post E. coli injection L.s.-infected dblGATA mice had 
significantly lower body temperatures than L.s.-infected BALB/c controls (Fig. 16A). 
Peritoneal bacterial loads of L.s.-infected dblGATA mice (Fig. 16B) were also increased 
compared to L.s.-infected wildtype controls, although not significantly. Concentrations of 
IL-6 (Fig. 16C), TNF (Fig. 16D), IL-10 (Fig. 16E) and MIP-2 (Fig. 16F) in L.s.-infected 
dblGATA mice were all increased when compared to L.s.-infected BALB/c controls, but the 
differences did not reach statistical significance.  
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Figure 16: Eosinophil-deficient dblGATA mice are only partly protected from E. coli sepsis 
Kinetics of sepsis induced hypothermia in L.s.-infected and E. coli-only treated dbl GATA mice and 
wildtype BALB/c controls (A). Peritoneal bacterial load six hours post E. coli challenge (B). Serum IL-
6 (C), TNF (D), IL-10 (E) and MIP-2 (F) -levels of mice six hours post E. coli injection. Data in (A) is 
presented as mean +/-SEM and was tested for statistical significance by 2-way ANOVA and 
Bonferroni post hoc tests. §-symbols indicate statistical significant differences between E. coli-only 
treated BALB/c and L.s.-inf. BALB/c; asterisks indicate statistical significant differences between 
L.s.-inf. BALB/c and L.s.-inf. dblGATA mice. Data in (B-F) was tested for statistical significance by 
Kruskal-Wallis ANOVA followed by Dunn’s post hoc test (*p<0.05, **p<0.01, ***p<0.001). 
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As expected, L.s. infection of dblGATA mice did not result in increased numbers of 
peritoneal eosinophils in response to E. coli injection (Fig. 17A). Similarly, frequencies of 
peritoneal F4/80+ macrophages were significantly lower in L.s.-infected dbl GATA mice 
compared to L.s.-infected wildtype BALB/c mice (Fig. 17B). Neutrophil numbers and 
frequencies were slightly, though not significantly, reduced in L.s.-infected dblGATA mice 
compared to the respective controls following E. coli challenge (Fig. 17C). 
 
 
 
 
 
 
 
  
Figure 17: Reduced frequencies of eosinophils and macrophages, but unchanged neutrophil 
frequencies after E. coli-challenge in L.s.-infected dblGATA mice. 
Peritoneal SiglecF+ eosinophils (A), F4/80+ macrophages (B) and GR1+ neutrophils (C) in chronic L.s.-
infected dblGATA and BALB/c mice and E. coli-only treated controls six hours after E. coli 
injection. Data is presented as median and was tested for statistical significance by Kruskal-Wallis 
ANOVA and Dunn’s post hoc test (***p<0.001; **p<0.01; *p<0.05). 
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3.2.5.2 Transfer of eosinophils is not protective in E. coli-induced sepsis 
The standard co-infection experiment using chronically infected dblGATA mice mentioned 
above revealed that L. sigmodontis-induced eosinophils may contribute to the attenuated 
sepsis response in L.s.-infected mice. In order to test the importance of eosinophils an 
eosinophil-transfer experiment was designed. Therefore, peritoneal cells of chronically 
infected mice were isolated by negative selection using magnetic beads (MACS) and a 
following adhesion step (Fig. 18). Isolated eosinophils were then transferred into the 
peritonea of naïve dblGATA mice and sepsis was induced 90 minutes later. This recipient 
group was compared to groups of uninfected and L.s.-infected BALB/c and uninfected 
dblGATA mice. 
Transfer of eosinophils into dblGATA mice (as performed in this experiment) did not 
improve sepsis parameters when compared to uninfected control BALB/c or dblGATA 
mice that did receive medium as control. Body temperature and bacterial loads were not 
significantly altered in the eosinophil-recipient group when compared to controls. 
Accordingly, systemic levels of IL-6, TNF, IL-1, IL-10 and IL-5 were similar to control 
groups (Fig. 19C, D, and not shown). Furthermore, composition of cell populations in the 
peritoneum was not affected by eosinophil transfer: macrophage (Fig. 19E) and neutrophil 
(Fig. 19F) numbers were not significantly different from controls. Expression of CD80 and 
CD86 on macrophages was similarly unaffected (not shown). This experiment did not 
demonstrate an essential contribution of eosinophils to the improved sepsis outcome in 
L.s.-infected mice. 
Given the differences seen in chronically infected dblGATA mice, the question arises if 
these differences are crucially connected to eosinophils or if there are more global defects 
in these mice that impair attenuation of sepsis by L.s. infection.   
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Figure 18: “Untouched” purification of eosinophils 
Plots showing the MFI of SiglecF-PE and F4/80-APC as well as dot blots showing frequencies of 
F4/80 and SiglecF positive cell populations from the eosinophil-depleted population and the 
eosinophil enriched population before and after an adhesion step. Peritoneal lavages of 14 chronic 
L.s.-infected (d90 p.i.) mice were pooled and incubated with anti-CD90.2, anti-MHC-II and anti-
B220 MACS beads for 15 minutes. After washing, cell suspension was run over a LD column (MACS 
Miltenyi) and the flow through (negatively selected fraction) was incubated for 15 min. After this 
adhesion step, non-adherent cells were counted and transferred to recipient mice by 
intraperitoneal injections. Purity of SiglecF+ eosinophils was >75%. 
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Figure 19: Transfer of eosinophils is not protective against E. coli-induced sepsis. 
Purified eosinophils were transferred to uninfected ΔdblGATA mice and parameters of E. coli-
induced sepsis were compared to vehicle injected uninfected ΔdblGATA, BALB/c and L.s.-infected 
BALB/c mice. (A) Kinetics of hypothermia in response to E. coli challenge. (B) Bacterial loads, serum 
levels of IL-6 (C) and TNFα (D) and peritoneal macrophage- (E) and neutrophil- (F) numbers six 
hours after E. coli injection. Data in (A) is presented as mean +/-SEM and was tested for statistical 
significance by 2-way ANOVA and Bonferroni post hoc tests. §-symbols indicate significant 
differences between U BALB/c and L.s.-inf. BALB/c; asterisks indicate significant differences 
between L.s.-inf. BALB/c and eosinophil recipient dblGATA mice. Data in (B-F) was tested for 
significance by Kruskal-Wallis ANOVA followed by Dunn’s post hoc test (*p<0.05, **p<0.01, 
***p<0.001). One representative of two similar experiments is shown. 
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3.2.6 Depletion of regulatory T cells has no effect on sepsis in L.s.-infected DEREG 
mice 
Six to eight week old BALB/c and DEREG mice were infected with L. sigmodontis by natural 
infection. At the time of chronic infection (day 90 p.i.) mice were injected with DTX at days 
-2 and -1 before sepsis induction. Depletion of Tregs was confirmed by gating on CD4- and 
CD25-positive cells, expressing eGFP in flow cytometry of blood and spleen (not shown).  
Treg-depleted DEREG mice were still protected from severe sepsis. Body temperature over 
the experimental time course of six hours (Fig. 20B) and also bacterial loads (Fig. 20A) and 
systemic IL-6 (Fig. 20C), TNF (Fig. 20D) and MIP-2 (Fig. 20E) levels after six hours were 
not significantly altered between L.s. infected and DTX treated DEREG and BALB/c mice. 
These results suggest a minor contribution of regulatory T cells to the L.s.-mediated 
protective effects in the acute response to E. coli sepsis.  
 
 
 
 
Figure 20: Depletion of regulatory T cells has no effect on sepsis in L.s.-infected mice. 
L.s. infected wildtype and DEREG mice were injected with diphtheria toxin two and one day 
before E. coli-challenge. Bacterial loads six hours post injection (A), Kinetics of hypothermia in 
response to E. coli challenge (B) and serum levels of IL-6 (C) and TNFα (D) and MIP-2 (E) six 
hours post E. coli injection. Data in (A, C-E) was tested for significance by Kruskal-Wallis ANOVA 
followed by Dunn’s post hoc test Data in (B) is presented as mean +/-SEM and was tested for 
statistical significance by 2-way ANOVA and Bonferroni post hoc tests.. One representative of 
two similar experiments is shown.. n≥8 per group.  
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3.2.7 Depletion of TGF reverted the protective effect of L. sigmodontis-infection 
on sepsis  
TGF is induced by L. sigmodontis infection and six hours after E. coli-induced sepsis, L.s.-
infected mice had significantly higher levels of circulating TGF than non-L.s.-infected 
controls (Fig. 21). This finding led to the hypothesis that TGF could be responsible for the 
attenuated innate response to E. coli-induced sepsis in L.s.-infected mice. To demonstrate 
the impact of L.s.-induced TGF on E. coli sepsis, TGF was depleted from L.s.-infected 
mice by injection of anti-TGF antibody (clone: 1D11.16.8) three and one day before sepsis 
induction. 
Six hours after E. coli injection body temperatures of L.s.-infected mice depleted of TGF 
were significantly lower compared to L.s.-infected mice that received control IgG (Fig. 22A). 
Similarly, serum MIP-2β, IL-6, IL-10 and TNF (Fig. 22C-F) concentrations as well as 
bacterial loads (Fig. 22B) were higher in the TGF depleted group, although statistical 
significance was only reached for comparisons on MIP-2β (Fig 22E). These results suggest a 
role for TGF in the attenuated sepsis response of L.s.-infected mice.  
 
 
 
 
 
 
 
Figure 21: TGF is increased in serum of chronic L. sigmodontis-infected mice after 
E. coli-challenge 
TGF concentrations in sera from chronic L. sigmodontis-infected wildtype mice and 
uninfected controls six hours after E. coli challenge. One representative of three 
experiments is shown. (Bars represent median; statistical significance was tested 
using Mann-Whitney-U test; *p<0.05 ) 
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Figure 22: The L. sigmodontis-mediated protective effect against sepsis is dependent on TGFβ 
Body temperature of mice injected with E. coli over the experimental time course of six hours (A). 
Bacterial loads (B) and serum TNFα (C), IL-6 (D), MIP-2β (E) and IL-10 (F) concentrations six hours 
post E. coli injection in L.s. infected (L.s.) and uninfected mice (U) that were either treated with 
anti-TGFβ (TGF) or received an isotype control (IgG1 ctrl). In A: “§” indicates statistical 
significant differences between U +IgG1 ctrl and L.s. IgG1 ctrl; “*” indicates statistical significant 
differences between L.s. + TGFβ and L.s. +IgG ctrl. *p<0.05, *** and §§§ p<0.001 as tested by 2-
way ANOVA and Bonferroni post hoc test (A) or Kruskal-Wallis one way ANOVA (B-F). 
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3.2.8 Neutrophil depletion impairs efficient bacterial clearance in both 
uninfected and chronic L.s.-infected mice 
Our previous experiments revealed increased numbers of neutrophils in L.s.-infected mice 
six hours after E. coli challenge. To test whether neutrophils play an essential role in our 
experimental setup, neutrophils were depleted in vivo by repeated injections of the anti-
Ly6G antibody 1A8 and sepsis was subsequently induced by E. coli injection. Neutrophil 
depletion was confirmed by FACS analysis of the peritoneal lavage using the GR1 antibody 
(Fig. 23A). Peritoneal neutrophil numbers were efficiently reduced by anti-Ly6G (1A8) 
injections (Fig. 23A). Depletion of neutrophils had only a minor effect on body temperature 
(Fig. 23B), whereas bacterial loads were significantly increased in neutrophil-depleted 
animals in both conditions six hours after E. coli challenge (Fig. 23C).  
 
 
 
 
 
 
 
 
 
Figure 23: Neutrophils contribute to bacterial clearance in E. coli-challenged mice. 
Frequencies of peritoneal Gr1+ neutrophils (A), body temperature over the experimental timecourse of 
six hours (B), and (C) peritoneal bacterial loads six hours after E. coli challenge in L.s. infected (L.s.) and 
uninfected mice (U) that were either treated with anti-Ly6G (1A8) or received an isotype control (iso). 
Data is presented as mean +/- SEM and was tested for statistical significance by Mann Whitney U test 
(A, C) or 2-way ANOVA with Bonferroni post hoc test. Asterisks in (B) represent statistical significant 
differences between L.s.+iso and U +iso treated mice. *p<0.05  
 
3 Results 
 
58 
 
3.2.9 L. sigmodontis-infection modulates peritoneal macrophage gene expression 
profiles 
Pairwise comparison of peritoneal macrophage gene expression from L.s.-only infected and 
naïve mice revealed an upregulation of phagocytosis associated genes (leptin receptor, 
mannose receptor) (Fig. 24A). Genes associated with alternative activation (RELM, YM1, 
Arginase-1) were upregulated in macrophages from L.s.-infected animals, although those 
changes did not reach statistical significance. On the other hand, signaling components of 
the inflammatory response were significantly downregulated in macrophages from L.s.-
infected mice (NFB p50, RelA, RelB, cRel, Traf6, TRIF, c/EBP, IRF5, TNFα (p>0.05)) 
compared to macrophages derived from naïve mice (Fig. 24A). The expression pattern of 
macrophages from L.s.-infected mice revealed therefore several features of alternative 
activation with a less inflammatory phenotype. Classic Th2-associated genes (e.g. IL-4, IL-
13) were not upregulated, supporting the image of a more regulatory/hypo-responsive 
phenotype, rather than a Th2-skewed inflammatory state at the chronic stage of L.s. 
infection. 
Comparative gene expression analysis of macrophages derived from septic mice without 
L.s. infection and naïve mice revealed an increased expression of genes associated with 
classical macrophage activation (e.g. CXCL10, iNOS, TNF, IL-12p35, CD40, CD80, CD86). 
Interestingly, Th2-associated genes (e.g. IL-4, CCL24) were simultaneously higher expressed 
(Fig. 24B, Fig.25). Generally, most genes were upregulated in the sepsis response of non-
L.s.-infected animals and expression of a vast number of different cytokines/chemokines 
(e.g. CXCL10, IL-4, TNF, IL-10, IL-12p35, CCL24) indicates the transcriptional basis for the 
cytokine storm in sepsis (Fig. 24B). Interestingly, CCL2, a monocyte recruitment factor, was 
the only gene downregulated following E. coli challenge. 
The gene expression pattern of macrophages derived from co-infected mice (L.s.+E.c. vs U) 
was less pro-inflammatory, compared to macrophages from E. coli-only treated mice (E.c. 
vs U). For example, co-stimulatory molecules like CD40, CD80 and CD86 were not 
upregulated in macrophages of co-infected mice (Fig. 24C, Fig. 25). Similarly, increased 
expression of cytokine genes was less abundant in macrophages of co-infected mice; only 
Th2 associated IL-13, anti-inflammatory IL-10 and TGF were significantly upregulated and 
sepsis-associated HMGB1 was downregulated (Fig. 24C). Most importantly, regulators of 
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NFB and TLR-signaling (A20/TNFAIP3, IB, SHIP-1, TOLLIP) were upregulated in 
macrophages from co-infected mice (Fig. 24C, Fig. 25), suggesting that these macrophages 
may be less responsive to TLR/NFB activating stimuli. Taken together analysis of gene 
transcription in peritoneal macrophages from L.s.-infected, E. coli-challenged mice 
demonstrated that the predominant macrophage phenotype is distinct from AAM and that 
immune modulation holds enhanced bactericidal features, besides hypo-responsiveness to 
TLR stimuli. 
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Figure 24: L. sigmodontis infection changes gene expression profiles of peritoneal macrophages 
Macrophages derived from uninfected and L.s.-infected mice three hours post E. coli injection and 
non-septic controls were analyzed for gene expression using a customized PCR-Array. Data is 
presented as fold change compared to naïve. Macrophage gene expression in L.s.-infected mice 
(A), in E. coli challenged mice (B) and L.s.-infected mice challenged with E. coli (C). n=3/group, cut-
off: 2-fold change and p<0.05 (RELM, YM1 and Arginase-1 in A are not significantly different from 
naïve controls). Differences were tested for statistical significance by student’s t test. Complete 
raw data is shown in Table S1. 
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Figure 25: Transcriptional analysis of peritoneal macrophages reveals a less inflammatory 
macrophage phenotype in L. sigmodontis-infected animals during E. coli-challenge. 
Gene expression of peritoneal macrophages of L. sigmodontis-infected, L. sigmodontis-infected 
and E. coli challenged as well as E. coli-only challenged mice in comparison to macrophages from 
naïve controls. Shared and exclusively regulated genes among the experimental groups compared 
to naïve control macrophage gene expression (cut-off: p<0.05 and >2-fold change). 
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When directly comparing macrophages from co-infected- and E. coli-only-infected animals, 
AAM-associated genes were differentially regulated: macrophages from co-infected mice 
had an increased expression of YM1 and Arginase-1, whereas RELM, acidic mammalian 
chitinase (AMCase) were unexpectedly downregulated compared to macrophages from E. 
coli-only treated mice (Fig. 26). Th2-associated genes were also downregulated in co-
infected mice (IL-4, IL-13, ST2) (Fig. 26). In consensus with the functional data, 
macrophages from co-infected mice preferentially expressed genes related to anti-
bacterial functions of macrophages like iNOS, C3 and C5a-Receptor. At the same time 
genes associated with regulation of TLR/NFB signaling (IKK, Socs3, IRAK-M) were higher 
expressed in macrophages from co-infected mice (Fig. 26).  
 
 
 
 
 
 
 
 
Figure 26: Comparison of E. coli-induced gene expression of peritoneal macrophages of L.s.-
infected and non-infected mice 
Macrophages derived from uninfected and L.s.-infected mice three hours post E. coli injection 
were analyzed for gene expression using a customized PCR-Array. Data is presented as fold change 
compared to E. coli-only mice (E. coli). n=3/group, cut-off: 2-fold change and p<0.05. Differences 
were tested for statistical significance by student’s t test. Complete raw data is shown in Table S1. 
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3.2.10 In vitro analysis of L. sigmodontis-derived antigen preparations 
3.2.10.1 Wolbachia-containing preparations of L. sigmodontis adult worms and 
insect cells induce TLR2-dependent secretion of TNF by macrophages in vitro 
Crude extracts from Brugia malayi have been previously shown to induce macrophage 
activation and pro-inflammatory cytokine production. The essential pattern recognition 
receptor mediating the response was demonstrated to be TLR2 and the respective ligand 
was found in the cell wall of endosymbiotic Wolbachia bacteria present in the extracts 
(Turner et al., 2006).  
In order to demonstrate Wolbachia- and TLR2-dependent activation of macrophages 
stimulated with L.s. antigen (LsAg), in vitro assays were performed using Thioglycollate-
elicited macrophages from naïve TLR2-/-, TLR4-/- and BALB/c wildtype mice. Macrophages 
were cultured in the presence of LsAg and an extract prepared from Wolbachia depleted 
L.s. (Ls-tet). Additionally, a preparation of insect cells containing Wolbachia (WOLB) and a 
respective Wolbachia-free insect cell preparation (C6/36) were used for stimulation. As 
controls, macrophages were stimulated with E. coli LPS (TLR4 ligand), Pam3Cys 
(TLR2/TLR1), FSL-1 (TLR2/TLR6) or medium. After 20 hours of culture, TNF concentrations 
in the supernatants were measured.  
As expected, LPS strongly induced TNF production from wildtype and TLR2-/- macrophages 
(Fig. 27A, C). Therefore data in figure 26A was normalized to LPS and is presented as 
percentage of LPS response. P3C and FSL-1 induced TNF responses only in wildtype, but 
not in TLR2-deficient macrophages, confirming purity of the compounds and TLR2 
deficiency of the cells. Similar to the established TLR2 ligands, LsAg induced TNF secretion 
only in wildtype, but not in TLR2-/- macrophages, demonstrating that TLR2 is essential for 
LsAg induced macrophage activation. Importantly, Wolbachia-free LsAg preparations 
activated TNF secretion only slightly in wildtype macrophages. Accordingly, Wolbachia 
containing insect cell preparations induced TNF in a TLR2 dependent manner, while 
Wolbachia-free insect cell preparation (C6/36) did not induce TNF production, neither in 
wildtype nor in TLR2-/- cells (Fig.27A). These results confirm previous reports that 
Wolbachia induce macrophage activation via TLR2. 
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Wildtype and TLR4-deficient macrophages responded to P3C stimulation with TNF 
secretion and TNFα data in figure 27B is presented as percentage of P3C response. LPS 
induced secretion of TNF was restricted to wildtype macrophages, whereas FSL-1, LsAg 
and WOLB induced TNF in wildtype and TLR4-/- macrophages to similar extents. No 
significant differences in TNF production in response to LsAg and WOLB were detected 
between macrophages from BALB/c wildtype and TLR4-/- mice (Fig.27). This suggests that 
TLR4 is dispensable for the recognition of Wolbachia-containing preparations like LsAg and 
WOLB. 
  
3 Results 
 
65 
 
 
 
 
 
 
 
Figure 27: Wolbachia-containing preparations of L. sigmodontis adult worms and insect cells 
induce TLR2-dependent TNFα secretion, whereas TLR4 is dispensable 
Thioglycollate-elicited peritoneal macrophages from wild type and either TLR2- (A, C) or TLR4-
deficient (B) mice were stimulated with TLR4- (E. coli-LPS) and TLR2- (P3C, FSL-1) specific ligands, L. 
sigmodontis adult worm extract (LsAg), LsAg from Wolbachia-depleted worms (Ls-tet), Wolbachia-
infected (WOLB) and sterile preparations of C6/36 insect cells. TNFα levels in the cell culture 
supernatant are shown normalized to LPS (A) and P3C (B) responses or as absolute concentrations 
(C). Data shown are representative of three independent experiments (n=5/group for (A, B) and 
n=4/group for (C)). Data shown is expressed as mean + SEM and was tested for statistical 
significance by student’s t-test. Asterisks above the bars indicate significant differences compared 
to medium controls. Statistics are not indicated for LPS, P3C and FSL-1. *p< 0.05; **p< 0.01; 
***p<0.001 
3 Results 
 
66 
 
3.2.10.2 Prior exposure to Wolbachia-derived TLR2 ligands renders 
macrophages hypo-responsive to subsequent LPS stimulation 
Endotoxin tolerance is a macrophage driven phenomenon that may occur in vivo and can 
be resembled in vitro. Macrophages are termed endotoxin tolerant if a prior encounter 
with endotoxin (homo-tolerance) or other TLR-ligands (hetero-tolerance) rendered them 
hypo-responsive to secondary stimulation with LPS (or other TLR ligands). 
As macrophages of L.s.-infected mice had a reduced activation upon E. coli challenge, it 
was hypothesized that Wolbachia induce a LPS-tolerant (hetero-tolerant) macrophage 
phenotype. To test this, thioglycollate-induced macrophages from wild type and TLR2-
deficient mice were primarily stimulated (prime) for 18 hours as described above before re-
stimulation with LPS for an additional 18 hours. Like P3C, prior exposure to Wolbachia 
containing extracts (LsAg, WOLB) elicited significantly lower amounts of TNFα (Fig. 28A) 
and reduced expression levels of CD40 (Fig. 28B) and MHC-II in response to LPS (fig. 28C). 
Priming with Ls-tet and C6/36 both failed to reduce TNF secretion and CD40/MHC-II 
expression in response to subsequent LPS stimulation. Importantly, macrophages derived 
from TLR2-deficient mice that failed to produce TNF in the primary response to 
Wolbachia containing preparations, consequently did not display LPS hypo-responsiveness 
(Fig. 28A, B, C). These results suggest that pre-exposure to TLR2 ligands and Wolbachia 
elicits hetero-tolerance that impairs subsequent macrophage activation by E. coli LPS via 
TLR4. 
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Figure 28: Prior exposure to Wolbachia-derived TLR2 ligands renders macrophages hypo-
responsive to subsequent LPS stimulation 
Thioglycollate-elicited peritoneal macrophages from wild type and TLR2-deficient mice were 
stimulated (prime) for 18 hours with TLR4- (E. coli-LPS) and TLR2- (P3C) specific ligands, L. 
sigmodontis adult worm extract (LsAg), LsAg from Wolbachia-depleted worms (Ls-tet), Wolbachia-
infected (WOLB) and sterile preparations of C6/36 insect cells before re-stimulation with LPS for an 
additional 18 hours. TNF levels in cell culture supernatant (A) and mean fluorescence intensity 
(MFI) of CD40 (B) and MHC-II (C) of F4/80+ macrophages are plotted relative to the acute LPS 
response (medium prime/LPS stimulation). Shown are data representative of three independent 
experiments (n=3 per group). Bars show mean +SEM and were tested for statistical significance by 
student’s t-test. Asterisks on top of the bars indicate significant differences compared to med/LPS 
conditions. Statistics are not indicated for LPS, P3C and FSL-1. (*p<0.05; **p<0.01; ***p<0.001) 
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3.2.10.3 Induction of LPS-hypo-responsiveness in macrophages by Wolbachia-
derived TLR2 ligands are inhibited by a TLR2-specific blocking antibody 
In order to test, if similar to TLR2-deficient macrophages, activation of TLR2 and 
subsequent hypo-responsiveness to LPS may be inhibited by anti-TLR2 blocking antibodies, 
macrophages were incubated with anti-TLR2 antibodies before the priming step with P3C, 
LsAg and WOLB. As expected, wildtype BALB/c macrophages pre-treated with an isotype 
control antibody showed LPS-hypo-responsiveness after priming with P3C, LsAg and WOLB, 
but not with medium or Ls-tet (Fig. 29). Similarly to TLR2-deficient macrophages, an initial 
blocking step to inhibit TLR2 mediated activation by an anti-TLR2 antibody impaired the 
effect of P3C, LsAg and WOLB in inducing hypo-responsiveness to LPS. LPS-induced homo-
tolerance was not affected by TLR2 blocking (Fig. 29). This experiment further supports that 
TLR2 is the functional receptor for Wolbachia derived PAMPs and that TLR2 binding to 
Wolbachia-derived ligands is required to induce LPS-hypo-responsiveness. 
 
 
 
 
 
 
 
 
Figure 29: Induction of LPS-hypo-responsiveness in macrophages by Wolbachia-derived TLR2 
ligands is inhibited by blocking TLR2 with specific antibodies 
Thioglycollate-elicited peritoneal macrophages from wild type and TLR2-deficient mice were first 
incubated 90 minutes in the presence of an anti-TLR2 antibody (T2.5) or an unspecific isotype control 
antibody (rat IgG) and then primed for 18 hours with TLR4- (E. coli-LPS) and TLR2- (P3C) specific 
ligands, L. sigmodontis adult worm extract (LsAg), LsAg from Wolbachia-depleted worms (Ls-tet) and a 
preparation of Wolbachia-infected insect cells (WOLB) before re-stimulation with LPS for an 
additional 18 hours. TNF levels in the cell culture supernatant of F4/80+ macrophage cultures are 
plotted relative to the acute LPS response (medium prime/LPS stimulation). Shown is data of one 
exemplary experiment (n=2 per group). Bars show mean + SEM and were not tested for statistical 
differences. 
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3.2.11 Wolbachia- and TLR2-mediated effects in co-infection 
3.2.11.1 TLR2 is essential for the L.s.-mediated protective effect in E. coli sepsis 
Our previous experiments revealed that L. s.-derived Wolbachia are sensed by TLR2 and 
induce a macrophage hypo-responsiveness to subsequent LPS stimulation. Thus, it was 
investigated, if TLR2-deficient BALB/c mice are still protected from E. coli-induced sepsis. 
The protective effect of chronic L.s. infection seen in BALB/c mice was prevented in TLR2-/- 
mice. As soon as four hours after E. coli injection body temperatures of L.s.-infected TLR2-/- 
mice was significantly lower than of L.s.-infected BALB/c controls and did not differ from 
non-L.s. infected, E. coli challenged TLR2-/- mice (Fig. 30A). After six hours, mice were killed 
and peritoneal lavage was analyzed for bacterial content and cellular composition. 
Bacterial loads were significantly reduced in L.s.-infected BALB/c mice, whereas TLR2-/- 
mice had a similar E. coli burden in the peritoneum as non-L.s.-infected controls (Fig. 30B). 
Chronic L.s.-infected TLR2-/- mice had significantly higher bacterial loads than L.s.-infected 
BALB/c mice (Fig. 30B). In line with body temperature and bacteremia, L.s.-infected TLR2-/- 
mice had higher serum levels of IL-6, IL-10, MIP-2 and TNF than L.s.-infected wildtype 
mice and comparable levels to E. coli-only TLR2-/- controls six hours post E. coli challenge 
(Fig. 30C). As opposed to E. coli-only challenged BALB/c mice, L.s.-infected and E. coli 
challenged BALB/c mice had higher peritoneal macrophage numbers following E. coli 
injection (Fig. 30D). In TLR2-/- mice, macrophage numbers were significantly lower 
compared to L.s.-infected BALB/c mice six hours after sepsis induction (Fig. 30D). Similarly, 
macrophages of L.s.-infected BALB/c mice expressed significantly lower levels of co-
stimulatory CD86 on their surfaces, compared to E. coli-only treated mice (fig. 30E). 
Macrophages derived from L.s.-infected TLR2-/- mice exhibited similar CD86 expression 
levels as E. coli-only treated controls and significantly higher CD86 expression levels than 
macrophages from L.s.-infected BALB/c mice (Fig. 30E). 
Survival experiments using L.s.-infected BALB/c and TLR2-/- mice and respective uninfected 
controls, revealed that the substantial survival benefit of L.s.-infected BALB/c mice in E. 
coli-induced sepsis was abrogated in TLR2-/- mice (Fig. 30F). All L.s.-infected TLR2-/- mice 
died within 22 hours post injection, whereas 40% of L.s.-infected BALB/c mice survived the 
bacterial challenge (Fig. 30F). Importantly, there was no significant difference between 
uninfected TLR2-/- and uninfected wildtype mice, indicating that TLR2 is not essential for 
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the response to gram-negative E. coli. Therefore, TLR2 is required for L. sigmodontis-
induced immunomodulation that is protective against E. coli-induced sepsis. Loss of 
protection was not due to an altered resistance of TLR2-/- mice to L.s. infection, as adult 
worm numbers in the pleural cavity and Mf loads in the peripheral blood were not altered 
in TLR2-/- mice at day 90 post infection compared to wildtype BALB/c mice. 
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Figure 30: TLR2 is required for the L.s.-mediated protective effect against E. coli-induced sepsis in 
vivo. 
(A) Kinetics of body temperature in response to i.p. E. coli injection of uninfected (U) and chronic L. 
sigmodontis (L.s.)-infected wild type and TLR2-deficient mice. (B) Peritoneal bacterial load, (C) serum 
concentrations of IL-6, IL-10, and MIP-2β, and TNFα, (D) total peritoneal F4/80hi macrophage 
numbers and (E) their mean fluorescence intensity (MFI) of CD86 six hours post E. coli injection. (F) 
Survival after i.p. injection of 6x108 cfu of E. coli into uninfected and L.s.-infected wild type and TLR2-
deficient mice. (A-D) shows a representative dataset from one of two independent experiments with 
at least 4 mice per group. Data shown in (A) is displayed as mean +SEM and was tested for statistical 
significance by 2-way ANOVA and Bonferroni post-hoc test (§-symbols indicate statistical significant 
differences between L.s.-infected and uninfected wild type mice and asterisks in comparison to L.s.-
infected TLR2-/- mice). Data shown in (B-E) was tested for statistical significance by 1-way ANOVA 
followed by Dunn’s post-hoc test. (F) presents pooled data from two independent experiments. 
Differences between L.s.-infected BALB/c and TLR2-/- mice were tested for statistical significance by 
Mantel-Cox Log-rank test (p=0.0035); (*p<0.05; **p<0.01; ***p<0.001). 
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3.2.11.2 Anti-bacterial effector mechanisms are enhanced by L. sigmodontis 
infection in a TLR2 dependent manner 
In order to further investigate the modulation of macrophage functions, uptake of E. coli 
and bacterial particles into macrophages was examined. Therefore, L.s.-infected BALB/c 
and TLR2-/- mice and their respective uninfected controls were injected with E. coli. Three 
hours after injection mice were killed and peritoneal macrophages were enriched by 
adherence and cultured in the presence of gentamicin. Cell culture supernatants were 
analyzed for nitric oxide and cells were lysed and plated on LB agar to determine colony 
forming units. Macrophages from L.s.-infected wildtype BALB/c, but not TLR2-/- mice took 
up significantly more E. coli (Fig. 31A) and produced more nitric oxide (Fig. 31B) than 
macrophages of uninfected controls. To confirm the improved phagocytosis in 
macrophages of L.s.-infected mice, mice were injected with fluorescently labeled pHrodo E. 
coli particles and after 1.5 and 3 hours peritoneal macrophages were analyzed by flow 
cytometry for the uptake of E. coli particles. The pHrodo particles are pH sensitive and 
therefore become only fluorescent in phagolysosomes. Macrophages of L.s.-infected 
BALB/c mice phagocytosed significantly more E. coli particles than macrophages of 
uninfected or L.s.-infected TLR2-/- mice (Fig. 31C). Similarly, phagocytosis of gram-positive 
Staphylococcus aureus pHrodo particles was significantly enhanced in macrophages of 
chronic L.s.-infected mice, compared to uninfected controls (Fig. 31D). 
The results of these experiments suggest that in L.s.-infected BALB/c mice macrophages 
have a stronger anti-bacterial capacity in terms of bacterial uptake and nitric oxide 
production than in uninfected mice that is not restricted to gram-negative, LPS containing 
bacteria. Here it was shown that TLR2 is essential in L.s.-infected mice to convey enhanced 
anti-bacterial functions to macrophages. 
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Figure 31: Anti-bacterial effector mechanisms are enhanced by L. sigmodontis infection in a 
TLR2-dependent manner. 
Colony forming units (cfu) obtained by a gentamicin assay using peritoneal macrophages 
derived from chronic L. sigmodontis (L.s.)-infected wild type and TLR2-/- mice and respective 
uninfected controls three hours after i.p. E. coli injection (A). Nitrite concentrations (B) of the 
same macrophages as in (A) after ex vivo cultivation for 48 hours. Frequencies of peritoneal 
F4/80+ macrophages from L.s.-infected and uninfected wild type and TLR2-/- mice (n=5 per 
group) that phagocytosed pHrodoTM-E. coli-BioParticles® three hours post injection (C). 
Frequencies of peritoneal F4/80+ macrophages positive for S. aureus particles (D). (A) shows 
pooled data from two independent experiments with at least four mice per group. Data 
shown in (A-C) is illustrated as mean + SEM and was tested for statistical significance by 1-
way ANOVA followed by Dunn’s multiple comparisons test. Data in (D) is shown as mean + 
SEM and was tested for statistical significance by Mann-Whitney U test. (*p< 0.05; **p< 0.01; 
***p<0.001). 
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3.2.12 Preventive treatment with helminth-derived molecules 
3.2.12.1 Serial injections of Wolbachia-containing preparations improve E. coli-
induced sepsis in vivo  
To investigate whether repeated exposure to Wolbachia-containing preparations 
modulates macrophage functions and sepsis outcome, serial injections of LsAg, WOL, Ls-tet 
and P3C were performed and compared to the response of E. coli-challenged PBS-injected 
mice. In a total of three injections, 40µg of the respective preparations were injected every 
fourth day into naïve wildtype BALB/c mice and two days after the last injection the E. coli 
challenge was performed.  
Compared to PBS-injected controls, mice treated with Wolbachia-containing preparations 
or P3C showed an attenuated course of E. coli-induced sepsis. Body temperature after six 
hours was significantly improved in mice treated with LsAg, Ls-tet and P3C, whereas 
Wolbachia administrations only resulted in a trend to a milder hypothermia (Fig. 32A). 
Serial LsAg- and Wolbachia-injections significantly reduced peritoneal bacterial loads, 
whereas Ls-tet failed to improve bacterial clearance (Fig. 32B). Systemic cytokine levels six 
hours after E. coli challenge were reduced by injection of all compounds tested, but only 
LsAg and P3C significantly reduced cytokine levels compared to PBS controls (Fig. 32C, D, 
E). 
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On the cellular level only minor differences between the groups were detectable. 
Macrophage frequencies (Fig. 33A) and CD86 expression (Fig. 33B) were unaltered, 
whereas expression of CD14 was reduced in all groups compared to PBS-treated animals, 
reaching statistical significance for Ls-tet (Fig. 33C). Expression of Mannose receptor CD206 
was induced in macrophages of LsAg-treated mice and was significantly increase in 
comparison to PBS controls (Fig. 33D). Neutrophil recruitment was not clearly altered 
between all groups (Fig. 33E). Interestingly, only LsAg treatment induced recruitment of 
eosinophils to the peritoneum, whereas all other treatments including Ls-tet did not 
increase peritoneal eosinophil numbers, compared to PBS injected mice (Fig. 33F). 
Figure 32: Serial injections of Wolbachia-containing preparations improve E. coli-induced sepsis 
in vivo 
Mice were injected for a total of three times with 40µg of L. sigmodontis extract (LsAg), Wolbachia 
(WOLB) or Pam3Cys (P3C) every fourth day. Two days after the last injection sepsis was induced by 
i.p. E. coli injection. Body temperature (A), bacterial loads (B) and serum IL-6 (C) IL-1b (D) and TNF 
levels (E) six hours after injection compared to PBS injected controls. Data is shown as median and 
was tested for statistical significance using Kruskal-Wallis followed by Dunn‘s multiple comparisons 
test (*p< 0.05; **p< 0.01; ***p<0.001). One representative of three independent experiments is 
shown. 
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Figure 33: Serial injections of Wolbachia-containing preparations have minor effects on 
peritoneal cell populations 
Mice were injected three times with 40µg of L. sigmodontis extract (LsAg/Ls-tet), Wolbachia 
(WOLB), Pam3Cys (P3C) or PBS (200µl) every fourth day. Two days after the last injection sepsis 
was induced by i.p. E. coli injection. Frequency of F4/80+ macrophages (A), and mean 
fluorescence intensity of CD86 (B), CD14 (C) and CD206 (D) in the peritoneum (A). Frequencies 
of neutrophils (CD11b+, Gr1+) (E) and eosinophils (CD11b+, SiglecF+) (F). Data is shown as median 
and was tested using Kruskal-Wallis followed by Dunn‘s multiple comparisons test (*p< 0.05; 
**p< 0.01). One representative of three independent experiments is shown. 
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3.2.12.2 Pre-treatment with filariae-derived molecules alters peritoneal cell 
composition and activation, and influences systemic inflammatory cytokine 
levels in response to E. coli challenge 
The L.s.-derived proteins ALT (abundant larval transcript-1) and CPI-2 (cysteine protease 
inhibitor-2) have been reported to possess immunomodulatory features that shape the 
immune response to filarial infection, but also to bystander antigens. A third protein, ES-
62, derived from excretory/secretory products from the filarial nematode 
Acanthocheilonema viteae, which does not contain endosymbiotic Wolbachia bacteria, has 
similarly been shown to modulate inflammatory processes . 
In order to test whether a single injection of recombinant ALT-1, CPI-2 or ES-62 is sufficient 
to improve sepsis outcome after intra-peritoneal challenge with E. coli, 2µg of the 
compounds or sterile PBS were injected i.p. one day before E. coli challenge. 
Only CPI-2 treatment significantly improved body temperature in mice six hours after E. coli 
injection; whereas mice of all other treatment groups developed hypothermia similar to 
PBS injected mice (Fig. 34A). ALT and CPI-2 treated mice showed a trend to reduced 
peritoneal bacterial loads (p>0.05), whereas ES-62 treated mice had similar bacterial loads 
to PBS control mice (Fig. 34B).  
 
 
 
 
  
Figure 34: Single injection of filariae-derived molecules influences body temperature and bacterial 
loads in E. coli-induced sepsis. 
Mice were injected with 2µg of ALT, CPI-2 or ES-62 or 100µl PBS one day before E. coli challenge. 
Kinetic of body temperature of treated mice up to 6h after E. coli challenge (A) and peritoneal 
bacterial load 6h after E. coli challenge (B). Data was tested for statistical significance by 2-way 
ANOVA and Bonferroni post-hoc test (A), and Kruskal-Wallis followed by Dunn‘s post hoc test (B); 
(“*” indicate statistical significant differences between PBS and CPI-2 treated mice 6h post injection, 
p< 0.05) 
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Absolute numbers of F4/80+ macrophages in the peritoneum were significantly increased in 
ALT and CPI-2 treated mice compared to PBS injected animals six hours after E. coli 
challenge (Fig. 35A). Similarly, expression of co-stimulatory CD86 and MHC class 2 
molecules on macrophages were down-regulated by ALT and CPI-2 treatment (Fig. 35B, C). 
ALT significantly increased neutrophil recruitment to the peritoneum and decreased CD86 
and MHC-II expression on neutrophils (Fig. 35D, E, F). CPI-2 injection resulted in a trend for 
increased peritoneal neutrophil numbers, but had no impact on neutrophil activation, 
whereas ES-62 had no impact on neutrophil numbers or activation. Systemic IL-6 levels 
were significantly reduced in CPI-2 treated mice and by trend in ALT injected mice (Fig. 
35G). Furthermore, IL-1 and IL-10 levels in the serum were reduced by ALT and CPI-2 
treatment compared to ES-62 and PBS injected animals, although this difference did not 
reach statistical significance (Fig. 35H, I). ES-62 had no impact on systemic levels of all 
cytokines tested when compared to PBS treated control mice (Fig. 35G, H, I).  
The results of this experiment suggest that single injections with ALT and CPI-2 may 
improve E. coli-induced sepsis. It can be assumed that further optimization of 
administration regimens (routes and concentrations of administered compounds) should 
further improve the beneficial effects of those helminth-derived molecules, including ES-
62, on E. coli challenge. 
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Figure 35: Pre-treatment with filariae-derived molecules alters peritoneal cell composition and 
activation, and influences systemic cytokine responses to E. coli-challenge. 
Total numbers of peritoneal macrophages (A) and neutrophils (D) and their CD86 (B, E) and MHC-II 
(C, F) expression levels (as MFI) six hours after E. coli challenge in animals that received a single 
injection of the indicated compound. Serum levels of IL-6 (G), IL-1β (H) and IL-10 (I) six hours after 
E. coli challenge. Data was tested for statistical significance by Kruskal-Wallis followed by Dunn‘s 
post hoc test (*p< 0.05; **p< 0.01; ***p<0.001).  
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3.2.13 Adoptive macrophage transfers 
3.2.13.1 Transfer of macrophages pre-treated with LsAg and Wolbachia improves 
E. coli-induced sepsis 
Macrophages from naïve BALB/c animals were pre-treated in vitro with LsAg or Wolbachia 
preparations and subsequently transferred to naïve recipient BALB/c mice. Twelve hours 
after transfer, mice were challenged i.p. with E. coli. Aliquots of the cells were further 
analyzed for LPS-tolerance and phagocytosis. 
Pre-treatment of wildtype macrophages with LsAg and Wolbachia preparations induced 
TLR2-dependent cytokine secretion (Fig. 36A), tolerance to subsequent LPS stimulation 
(Fig. 36B) and improved phagocytic uptake of pHrodo E. coli-particles in vitro (Fig. 36C). 
Importantly, equally treated TLR2-deficient macrophages did neither show LPS-tolerance 
nor improved phagocytosis of E. coli particles (Fig. 36B, C). 
In vivo, transferred macrophages from all conditions lessened E. coli-induced hypothermia 
(Fig. 37A) and reduced systemic pro-inflammatory cytokine levels (Fig. 37C) compared to 
mice that received no cells. Nevertheless, wildtype macrophages pre-treated with LsAg or 
Wolbachia further improved body temperature (Fig. 37A) and reduced bacterial loads (Fig. 
37B) as well as systemic IL-6 (Fig. 37C) and MIP-2 (Fig. 37D) of recipient mice more 
efficiently, whereas transfer of TLR2-/- macrophages did not show additional advantageous 
effects, when equally pre-treated (Fig.37A-D).  
These experiments demonstrate that by in vitro pre-treatment with LsAg or Wolbachia 
macrophages can exert enhanced anti-bacterial functions in vivo, in a TLR2 dependent 
manner.  
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Figure 36: Pre-treatment of macrophages with LsAg or Wolbachia induces TLR2-dependent 
cytokine secretion, hypo-responsiveness to LPS re-stimulation and enhanced phagocytosis 
Thioglycollate-elicited macrophages derived from BALB/c and TLR2-/- mice were treated 
with LsAg or Wolbachia and compared to medium controls. IL-6, TNFα, IL-1β and MIP-2β 
levels 24 hours after stimulation (A). TNF secretion in response to LPS re-stimulation (B) 
and phagocytosis of pHrodo E. coli particles (C). Data is shown as percentage of medium-
treated controls (B, C). Data is presented as single values (A, B) or mean +/- SEM of 
duplicates (C) and was tested for statistical significant differences by Kruskal-Wallis and 
Dunn’s post hoc test (**p<0.01; ***p<0.001; ns p>0.05). 
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Figure 37: Transfer of macrophages pre-treated with LsAg and Wolbachia improves E. 
coli-induced sepsis 
TLR2-/- and wildtype macrophages were pre-treated with LsAg, Wolbachia (WOL) or 
medium (med) and transferred to naïve recipient BALB/c mice. 12 hours after 
macrophages transfer sepsis was induced by i.p. E. coli injection. Body temperature (A), 
peritoneal bacterial loads (B) and serum IL-6 (C) and MIP-2β (D) levels were measured 
six hours after E. coli challenge. Data is shown as mean +/-SEM and tested for significant 
differences by Kruskal-Wallis and Dunn’s post hoc test (*p<0.05; **p<0.01; ***p<0.001; 
ns p>0.05). In C and D data is presented as percentage of medium (med). 
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3.2.13.2 Transfer of macrophages from L.s.-infected mice to naïve recipients 
attenuates E. coli-induced systemic inflammation 
In order to test the effect of macrophages derived from L.s.-infected mice on the systemic 
inflammatory response to E. coli challenge, peritoneal macrophages from chronic L.s.-
infected wildtype BALB/c and TLR2-/- mice were isolated and transferred into naïve BALB/c 
recipients. Sixteen hours after the adoptive transfer, mice were challenged with E. coli. 
Compared to PBS treated naïve mice, body temperature was only significantly improved in 
mice that received macrophages from L.s.-infected WT mice (Fig. 38A and B). However, 
transfer of macrophages derived from all conditions improved bacterial clearance from the 
peritoneum, compared to controls that received no cells (Fig. 38C). Similarly, macrophages 
transferred from L.s.-infected BALB/c mice reduced bacterial loads and serum TNF, MIP-
2 and IL-1 levels more efficiently, compared to mice that received macrophages from 
naïve BALB/c mice (Fig. 38D and E). Importantly, no significant differences were detectable 
between mice that received macrophages from L.s. infected TLR2-/- mice and mice that 
received macrophages from naïve BALB/c controls (Fig. 38D and E). Taken together, this 
experiment demonstrates the advantage of functionally modulated macrophages derived 
from L.s.-infected BALB/c mice, compared to macrophages from naïve animals. 
Furthermore, the beneficial modulation of macrophages in L.s.-infected mice seems to be 
partly dependent on TLR2-derived signals, since macrophages from L.s.-infected TLR2-/- 
mice improved sepsis only to the extend naïve wildtype macrophages did. 
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Figure 38: Transfer of macrophages derived from chronic L.s.-infected donors to naïve 
recipient mice improves E. coli-induced sepsis 
Macrophages derived from chronic L.s.-infected BALB/c and TLR2-/- mice and naïve BALB/c 
mice were transferred to naïve BALB/c recipient mice. Sixteen hours after macrophage 
transfer, mice were challenged by i.p. E. coli injection. Body temperature (A, B), peritoneal 
bacterial loads (C) as well as serum levels of MIP-2β (D) and IL-1β (E) are depicted at six hours 
post E. coli injection. Data is shown as mean +/-SEM and tested for statistical significant 
differences by 2-way ANOVA and Bonferroni multiple comparisons test (A) or shown as 
median (red line) and tested by Kruskal-Wallis and Dunn’s post hoc test (*p<0.05; **p<0.01; 
***p<0.001). (A) “*” indicates differences between macs[L.s. WT] and macs[L.s. TLR2-/-]; § 
indicates the difference between macs[L.s. WT] and macs[U WT].  
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4 Discussion 
The human immune system evolved in the presence of parasitic infections (Maizels and 
Yazdanbakhsh, 2003; Okin and Medzhitov, 2012). Due to improved hygiene helminth 
infections became rare in western civilizations over the last decades and this may has led 
to an imbalanced immune system that not only favors the development of autoimmune 
diseases, but may also promote exacerbated pro-inflammatory immune responses during 
bacterial infections leading to sepsis (Weinstock and Elliott, 2014). 
 
4.1 Chronic Litomosoides sigmodontis infection has several features that 
may improve sepsis 
Similar to human pathogenic filariae, Litomosoides sigmodontis infection is associated with 
systemic and local changes of the immune system (Allen and Maizels, 2011; Hoerauf et al., 
2005; Maizels et al., 2004). Thus, attenuation of systemic inflammation and improvement 
of bacterial clearance in sepsis is probably due to the interplay of many cellular, but also 
soluble components. The most prominent cellular alterations become visible at the local 
site of infection, the pleural cavity. Increased numbers of neutrophils and eosinophils as 
well as IL-4R-dependent alternatively activated macrophages are prominent hallmarks of 
L. sigmodontis infection in mice. This is similarly seen in histology of filariae-infected 
human patients and other animal models (Brattig et al., 2001, 2010; Dash et al., 2011; 
Makepeace et al., 2012). Neutrophils possess potent anti-microbial functions through 
production of neutrophil extracellular traps (NETs) and a strong phagocytic activity (Craciun 
et al., 2010). Granule proteins of eosinophils (e.g. Eosinophil Cationic Protein, ECP and 
Major Basic Protein, MBP) also have direct anti-bacterial capacity, thus eosinophils may 
also contribute to bacterial killing (Linch et al., 2009). The AAM phenotype of macrophages 
is thought to be less effective against bacteria than classically activated macrophages, 
nevertheless it has been shown that AAM can be reprogrammed to serve anti-microbial 
purposes (Mylonas et al., 2009). Systemically, concentrations of eosinophil-associated 
cytokines and chemokines like IL-5 and Eotaxin-1 (CCL11) and macrophage-associated TGF 
and MCP-2 (CCL8) are increased in the peripheral blood of infected mice. This is part of the 
systemic immune modulation of L. sigmodontis and may influence the outcome of bacterial 
infections. Mice mount an antibody response against Litomosoides- and Wolbachia-derived 
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antigens which help to contain the filarial infection and may contribute to immune 
regulation. Filarial infections in humans share similar characteristics (Adjobimey and 
Hoerauf, 2010; Adjobimey et al., 2013); from this point the findings from this thesis may be 
translated to the human situation. 
L.s. infection induced increased levels of TGF in peripheral blood of mice. In a previous 
study our group was able to demonstrate that L.s. infection prevented the onset of Type 1 
diabetes in nonobese diabetic (NOD) mice in a TGFβ dependent manner (Hübner, …, 
Gondorf et al., 2012a). Here it was shown that antibody mediated depletion of TGF 
reverted the protective effect of L.s. infection on sepsis. Body temperature and systemic 
MIP-2β levels were significantly worsened when compared to L.s.-infected mice that were 
injected with a control antibody. This suggests that L.s.-induced TGF contributes 
essentially to the immune modulation that confers protection against E. coli-induced 
sepsis, similarly to the prevention of diabetes. In regard to the observed macrophage 
modulation in this study, L.s.-induced TGF may induce an anti-inflammatory phenotype in 
macrophages (Grainger et al., 2010) and also may enhance phagocytosis.  
 
4.2 Regulatory T cells, IL-10 and CARS 
It has previously been shown that L. sigmodontis infection induces regulatory T cells (Treg) 
(Dittrich et al., 2008; Grainger et al., 2010; Hübner et al., 2009, 2012a); these cells 
contribute to the establishment of an anti-inflammatory milieu mainly by secreting IL-10 
(Daniłowicz-Luebert et al., 2011) and TGFor by acting in a cell contact dependent 
manner. In sepsis and endotoxemia models IL-10 was demonstrated to be essential for a 
balanced immune response to bacteria or LPS (Lenz et al., 2007; Pils et al., 2010) and the 
subsequent development of a compensatory anti-inflammatory response syndrome (CARS) 
(Aziz et al., 2012; Biswas and Lopez-Collazo, 2009; Hotchkiss et al., 2009; Latifi et al., 2002). 
Mice deficient for IL-10 showed severe organ failure and increased mortality after bacterial 
challenge (Sewnath et al., 2001), whereas administration of recombinant IL-10 dampened 
excessive inflammation and improved survival (Matsumoto et al., 1998; Steinhauser et al., 
2014). For our co-infection experiments using DEREG mice, it was therefore hypothesized 
that regulatory T cells may be an essential factor for the attenuation of the pro-
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inflammatory response in bacterial sepsis. Depletion of regulatory T cells, one of the major 
IL-10 producing cell populations, could have a negative impact on sepsis outcome through 
abrogation of IL-10-mediated downregulation of the pro-inflammatory response seen in 
L.s.-infected mice. Another mode of action of L.s.-induced Treg could be the inhibition of 
potentially detrimental actions of effector T cells in sepsis, as effector T lymphocytes play 
important roles for the initiation of pro-inflammatory responses in bacterial sepsis (Kasten 
et al., 2010). However, chronic L.s.-infected DEREG mice depleted from Treg shortly before 
sepsis induction showed similar values for hypothermia, bacterial loads and systemic TNF, 
IL-6 and MIP-2β levels, compared to chronic L.s.-infected BALB/c controls, demonstrating 
that Treg depletion from L.s.-infected mice did not prevent the improved sepsis outcome. 
Thus, an impact of regulatory T cells on the acute phase of E. coli-induced sepsis in L.s.-
infected mice was absent. 
Regulatory T cells further contribute to the establishment of the hyporesponsive CARS 
phase, which follows the pro-inflammatory SIRS phase during sepsis (Monneret et al., 
2003; Schwandt et al., 2012; Venet et al., 2009). To complement the observations made on 
the L.s.-mediated effect on the acute phase of sepsis, the impact of L.s. infection on the 
development of CARS after bacterial challenge was investigated in a parallel diploma thesis. 
Here, sepsis induced T cell paralysis was not influenced by pre-existent L.s. infection 
(Buerfent, Gondorf et al., 2014). Nevertheless, the study nicely showed that in the absence 
of a bacterial challenge L.s. infection significantly reduced cytotoxic T cell function to a 
similar extent as seen in septic T cell paralysis. 
Interleukin-10 is thought to keep the initial pro-inflammatory response in check and, as a 
consequence is triggered by the same stimuli (Aziz et al., 2012; Pils et al., 2010; Sabat et al., 
2010). Thus, during the acute sepsis response IL-10 was induced as well as IL-6 and TNF 
but with delayed kinetics. Accordingly, L.s.-infected mice had reduced IL-10 levels after E. 
coli challenge, when compared to E. coli-only treated mice and IL-10 levels were not 
detectable in the absence of E. coli in both control groups. Consequently, the protective 
effect of L.s. infection on E. coli sepsis is unlikely to stem from elevated IL-10 levels in L.s.-
infected mice.  
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4.3 Eosinophils probably have an indirect role 
Eosinophils potentially possess a central role in the protective effect of L.s. infection on 
sepsis outcome. On the one hand, increased eosinophil numbers are a hallmark of 
helminth infections, being essential for protective immune responses against helminths 
(Cadman et al., 2014; Klion and Nutman, 2004; Specht et al., 2006; Volkmann et al., 2003b), 
whereas a loss of eosinophils is associated with severe sepsis (Abidi et al., 2008; Garnacho-
Montero et al., 2014). To test the hypothesis that eosinophils have a central role in the L.s.-
mediated protective effect on sepsis, eosinophil-deficient dbl GATA mice were used in the 
co-infection experiments. Although statistical significance was not reached, chronic L.s.-
infected dbl GATA mice were not protected from severe sepsis. Peritoneal bacterial loads 
and systemic cytokine/chemokine concentrations were increased, compared to L.s.-
infected wildtype BALB/c mice six hours post E. coli challenge, suggesting that eosinophils 
contribute to the L.s.-mediated protective effect in E. coli sepsis. Nevertheless, dbl GATA 
mice, which are deficient for the transcription factor GATA-1, have several features besides 
deficiency for mature eosinophils. For example basophil and mast cell populations are also 
compromised in these mice (Nei et al., 2013). Importantly, in this study macrophage 
numbers were strongly reduced in the peritonea of L.s.-infected dbl GATA mice, 
suggesting that eosinophils may have a role in the recruitment of macrophages to the 
peritoneum. Since an initial eosinophil transfer experiment failed to improve sepsis 
outcome, further investigation is needed to confirm the role of eosinophils in this context, 
testing their direct or indirect role in the L.s.-mediated protective effect in E. coli sepsis.  
 
4.4 Macrophages contribute significantly to the L.s.-mediated 
improvement of sepsis outcome 
Macrophages represent a diverse and plastic entity, capable of initiating and modulating 
both innate and adaptive immune responses (Biswas and Mantovani, 2010; Mosser and 
Edwards, 2008). In recent years it has become apparent that macrophage differentiation is 
neither terminal nor restricted to polarized phenotypes (M1/M2), but must rather be 
regarded as an result of integrated signals received in a specific microenvironment in order 
to execute specialized functions (Gordon and Martinez, 2010; Lavin et al., 2014; Murray et 
al., 2014; Wynn et al., 2013; Xue et al., 2014).  
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In the absence of E. coli challenge, macrophages in the peritoneum of chronic L.s- infected 
mice were only slightly modulated, displaying moderately increased expression of genes 
that correlate with an AAM phenotype (mannose- and leptin-receptor, RELM, YM1, 
Arginase-1). Increased expression of the mannose receptor, which was previously 
associated with helminth immunomodulation (Guasconi et al., 2011) and phagocytosis 
(Gazi and Martinez-Pomares, 2009; Stein et al., 1992), may account for the improved 
phagocytic uptake of bacteria in this thesis. On the other hand, downregulation of genes 
associated with the TLR and NFκB signaling pathway indicate that peritoneal macrophages 
of L.s.-infected mice may exert altered intracellular signaling in response to TLR ligation. 
Macrophages play a pivotal role during sepsis (Amersfoort et al., 2003; Cailhier et al., 2005; 
Murray and Wynn, 2011) since they sense pathogens via pattern recognition receptors and 
initiate immune responses through the release of pro-inflammatory and chemotactic 
mediators. These cells also have an important role in the elimination of pathogens via 
phagocytosis and production of bactericidal reactive oxygen and nitrogen species. In this 
thesis, it was demonstrated that functional reprogramming of macrophages by either 
chronic infection with the filarial nematode L.s. or repeated i.p. injections with filarial 
antigens improve the outcome of E. coli-induced sepsis. 
The importance of macrophages for the outcome of sepsis was emphasized by macrophage 
depletion and transfer experiments. In E. coli-only treated mice macrophage-depletion 
worsened E. coli-induced hypothermia supporting a generally protective role of peritoneal 
macrophages in sepsis. Peritoneal bacterial load and systemic pro-inflammatory 
cytokine/chemokine levels were not influenced. In co-infected mice macrophage-depletion 
reverted the improved sepsis outcome seen in PBS-liposome injected control mice.  
Transfer of unprimed macrophages lessened E. coli-induced hypothermia and systemic pro-
inflammatory cytokine/chemokines levels, but failed to significantly reduce bacterial 
burden, compared to PBS injected control mice. In vitro priming with L.s./Wolbachia-
derived TLR2 ligands preceding transfer further improved sepsis parameters and also 
bacteremia significantly. These results indicate that macrophages generally contribute to 
immune responses that prevent sepsis, but also that preceding signaling events modulate 
their anti-bacterial functions in order to facilitate their protective capacity in sepsis.  
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Gene expression analysis of macrophages from chronic L. sigmodontis-infected E. coli-
challenged mice revealed upregulation of the anti-inflammatory cytokines IL-10 and TGFβ 
as well as negative regulators of TLR signaling and NFκB activation (A20/TNFAIP3, TOLLIP, 
SHIP-1, IκB), which were previously associated with hypo-responsiveness to LPS during 
endotoxin tolerance (Liew et al., 2005). For example a recent report demonstrated that 
expression of the de-ubiquitinase A20 is essential to induce LPS tolerance and that A20 
deletion in dendritic cells renders mice hyper-responsive to LPS challenge. Similarly, 
macrophages from these mice downregulated the expression of HMGB1, F4/80 and TRAM 
genes. This further supports the image of an anti-inflammatory phenotype of these 
macrophages that may benefit sepsis outcome, since HMGB1 is known as a sepsis 
promoting cytokine and TRAM is involved in the signaling cascade downstream of TLRs, 
whereas F4/80 is known to be regulated on the cell surface in response to activation. While 
genes associated with anti-inflammatory immune responses (IL-10, TGFβ, SHIP-1, TOLLIP, 
IκB) were also upregulated in macrophages from E. coli-only challenged mice (that is, co-
regulated), pro-inflammatory cytokines and chemokines (TNFα, IL-12p35, CXCL10, IFNγ) 
were exclusively upregulated. Reduced expression of CD80 and CD86 on macrophages 
from co-infected mice was observed by flow cytometry and confirmed on RNA level, 
whereas IL-6 expression of macrophages was inconsistent with IL-6 levels measured in the 
peripheral blood. This may suggest that serum IL-6 concentrations are not mainly derived 
from peritoneal macrophages.  
Consistent with previously described functions of nitric oxide (NO), upregulated iNOS 
expression and enhanced NO production of peritoneal macrophages derived from L. 
sigmodontis-infected mice correlated with improved bacterial clearance and survival of the 
corresponding mice. Preferential expression of mannose receptor and C5a-receptor may 
contribute to enhanced phagocytic activity in chronic L.s.-infected BALB/c mice (Gazi and 
Martinez-Pomares, 2009; Rittirsch et al., 2008b). Taken together these macrophage-
features amplify bacterial killing and uptake, facilitating an attenuated systemic response 
to bacterial challenge. 
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4.4.1 IL-4, IL-4R and the AAM phenotype 
IL-4Rα dependent AAM are induced by helminth infections and are thought to be 
important for regulation of parasitemia and pathology (Ludwig-Portugall and Layland, 
2012; Maizels and Yazdanbakhsh, 2008; Sawant et al., 2014). Here, this is supported by the 
fact that mice deficient for IL-4 or IL-4Rα display massively enhanced parasitemia with 
increased adult worm burdens in the pleural cavity, high microfilaria loads in the peripheral 
blood and splenomegaly.  
While AAMs are commonly linked to a higher susceptibility to bacterial infections (Potian et 
al., 2011; Su et al., 2012), it has also been shown that by TLR stimulation AAM may be 
reprogrammed to enhance their bactericidal capacity (Mylonas et al., 2009). Additionally, 
AAM may have beneficial effects by lessening sepsis-induced tissue damage, since AAM 
have been shown to contribute to wound healing and resolution of inflammation (Loke et 
al., 2000; Thomas et al., 2012). Here it was found that peritoneal macrophages expressed 
RELMin L.s.-infected wildtype mice six hours post E. coli challenge. This was unexpected, 
as in L.s.-only treated mice, increased RELM expression was restricted to macrophages 
residing in the pleural cavity (the local site of L.s. infection). Although L.s. infection induced 
AAM in the pleural cavity and peritoneal macrophages expressed RELM upon E. coli 
challenge in BALB/c mice, co-infection experiments in IL-4R/IL5-/- and IL-4-knock-out mice 
revealed that host IL-4, IL-4R, and RELM-expressing macrophages were dispensable for 
the L.s.-mediated improved sepsis outcome. Taken together, this suggests that L.s. 
infection primes macrophages towards a specialized phenotype that differs from IL-4Rα-
driven AAM phenotypes. 
Additional characteristics of in vivo L.s.-exposed peritoneal macrophages during E. coli 
challenge were increased release of nitrogen species, improved phagocytosis and bacterial 
clearance. Enhanced bacterial uptake is probably not restricted to certain pathogens, since 
E. coli- and S. aureus-particles and fluorescent beads were taken up more efficiently by 
peritoneal macrophages of L.s.-infected mice, suggesting a potentially protective effect 
also in poly-microbial sepsis models (e.g. CLP, CASP) or other sepsis-inducing bacterial 
infections (e.g. S. aureus, P. aeruginosa). 
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4.4.2 Wolbachia, TLR2 and cross-tolerance 
In vitro experiments from this thesis demonstrate that stimulation of macrophages with 
LsAg or a preparation of Wolbachia-infected insect cells induced macrophage activation 
and pro-inflammatory cytokine release. Furthermore, subsequent LPS-induced macrophage 
activation was diminished in a TLR2- and Wolbachia-dependent manner. 
The relevance of TLR2 signaling for the L. sigmodontis-mediated protection against E. coli-
induced sepsis was also shown in vivo. Co-infection experiments revealed that TLR2-
deficient mice did not have an improved sepsis outcome when infected with L. 
sigmodontis. Lack of protection was not due to an overall increased susceptibility of TLR2 
deficient mice to E. coli, since in the absence of L.s. infection wild type and TLR2 deficient 
mice responded equally to an E. coli challenge. This confirms previous reports that did not 
find an altered pathology in TLR2-/- mice following E. coli–induced sepsis (Roger et al., 
2009). Parasite burden was also unaltered between TLR2-deficient and wild type BALB/c 
mice, excluding the possibility that differences in parasite load were the cause for the 
reverted sepsis phenotype. Instead it was found in independent assays that compared to 
macrophages from L. sigmodontis-infected wildtype BALB/c mice, macrophages from L.s.-
infected TLR2-deficient mice had a reduced phagocytic capacity. Similarly, production of 
anti-bacterial nitric oxide from macrophages was impaired in L. sigmodontis-infected TLR2-
/- mice. These findings suggest that TLR2 is not directly required for resistance to E. coli and 
L. sigmodontis, but is rather utilized to improve macrophage functions that are protective 
in E. coli-induced sepsis.  
As Wolbachia and LsAg-derived TLR2 signaling was efficient to induce hypo-responsiveness 
to LPS in vitro, it was further investigated if repeated i.p. administration of Wolbachia and 
Wolbachia-containing LsAg improved bacterial sepsis in vivo. Consistent with the in vitro 
data and previously reported studies using different TLR2-ligands (Buckley et al., 2006; 
Deiters et al., 2003; Feterowski et al., 2005), repeated injections of Wolbachia and LsAg 
induced hetero-tolerance of macrophages to E. coli and improved sepsis outcome in vivo. It 
can be assumed that similar to serial injections of bacterial lipoproteins, protective 
macrophage functions like phagocytosis and nitric oxide production become enhanced by 
repeated (or persistent) exposure to Wolbachia and thereby protect mice from severe 
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sepsis symptoms (Li et al., 2006; Wang et al., 2003). Presumably, the TLR2 ligand active in 
LsAg and insect cell-derived Wolbachia preparations is similarly a bacterial lipoprotein. 
The observed partial improvement of E. coli-induced sepsis by pre-treatment of animals 
with filarial extracts obtained from tetracycline-treated worms is probably due to 
incomplete Wolbachia-depletion. Additionally, Wolbachia independent components of Ls-
tet like for example cuticle-derived chitin may explain the observed recruitment of 
granulocytes and macrophages and milder E. coli-induced hypothermia.  
 
4.4.3 Transfer of primed macrophages affects local and systemic features of 
sepsis 
In order to demonstrate that peritoneal macrophages become functionally reprogrammed 
by Wolbachia-derived TLR2 signaling and that these cells improve E. coli-induced sepsis on 
a systemic level, macrophage transfer experiments were designed. Macrophages from 
BALB/c and TLR2-/- mice were stimulated in vitro with Wolbachia or LsAg and TLR2 
dependent induction of hypo-responsiveness to LPS and improvement of phagocytosis was 
confirmed in vitro. Comparison of mice that received in vitro stimulated macrophages from 
either wild type or TLR2 deficient mice demonstrated that exposure of macrophages to 
Wolbachia or LsAg improved E. coli-induced sepsis in a TLR2 dependent manner. This 
experiment demonstrated that macrophages become functionally superior by TLR2-
mediated sensing of Wolbachia and that these macrophages have protective effects in vivo 
against E. coli-induced sepsis. 
Finally, macrophages transferred from chronically infected L. sigmodontis mice into naïve 
recipient mice improved sepsis outcome more efficiently than macrophages derived from 
L. sigmodontis-infected TLR2 deficient or naïve wild type mice.  
Both types of macrophage transfer experiments demonstrate that on the one hand 
increased peritoneal macrophage numbers have beneficial effects against an i.p. E. coli 
challenge, but also that functional reprogramming of macrophages can further enhance 
this protective effect. An interesting study supporting the benefit of macrophage 
modulation, demonstrated that transfer of immunomodulary M2 macrophages prevents 
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Type 1 Diabetes in NOD mice (Parsa et al., 2012). Similarly, transfer of a CD209a-positive 
macrophage population protected mice against bacterial sepsis (Lu et al., 2013). 
Presumably, the beneficial systemic effect of peritoneal macrophage transfer is due to the 
enhanced bacterial control and reduced cytokine secretion in response to E. coli LPS 
leading to alleviated immune-mediated pathology.  
 
4.4.4 Impact of helminth co-infections and helminth-derived molecules on 
bacterial infections, LPS-sensing and intracellular signaling  
In this thesis it was demonstrated that chronic L.s. infection had beneficial effects on E. 
coli-induced sepsis. Bacterial clearance was improved, while TLR4-activated secretion of 
pro-inflammatory mediators was diminished. These features correlated with enhanced 
macrophage phagocytosis and NO production, at the same time macrophages were less 
apoptotic and expressed lower levels of co-stimulatory molecules. These characteristics are 
in accordance with attributes previously described for endotoxin tolerant macrophage 
populations (Biswas and Lopez-Collazo, 2009; de Lima et al., 2014). 
While in this thesis a protective effect of filarial infection on sepsis was demonstrated, 
several animal models investigating helminth-bacteria co-infections led to variable findings. 
Several concurrent helminth infections had detrimental effects on bacterial infection or 
endotoxin challenge, whereas others improved bacterial clearance and dampened LPS-
induced inflammatory responses (Hübner et al. 2013). Over all it appears that outcomes 
are highly dependent on the combination of bacterial and helminth species, their 
associated immune features and the readout assessed (e.g. bacterial clearance, systemic 
cytokines, macrophage activation, survival, etc.), (Hübner et al., 2013; Salgame et al., 
2013). 
IL-4R dependent AAM impair protective immune responses to some bacterial species 
(Potian et al., 2011; Rook, 2009; Su et al., 2012), whereas other studies suggested that 
helminth infection may improve bacterial control and/or ameliorate the detrimental 
effects of LPS-induced septic shock (Erb et al., 2002; Hübner et al., 2012b; du Plessis et al., 
2012; Sutherland et al., 2011).  
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By the use of AAM-deficient IL-4 and IL-4R/IL-5 knockout mice it was shown that, 
although AAM are induced by chronic L.s. infection in wildtype mice, AAM were 
dispensable for the attenuated sepsis outcome in L.s./E. coli co-infected mice. Therefore, 
impairment of Th1-type immunity through macrophage polarization towards a Th2 
immune response by L.s. infection does not account for the attenuated sepsis outcome. 
Similarly, several studies did not find impaired bacterial clearance by pre-existing helminth 
infections and associated Th2 type immunity (Frantz et al., 2007; du Plessis et al., 2012; 
Sutherland et al., 2011). Thus, a study using implanted prepatent adult L. sigmodontis 
worms found reduced systemic cytokine levels after endotoxin challenge (Hübner et al., 
2008). However, this study observed a fatal outcome in mice that were injected with 
microfilariae. In the current thesis no association of blood mf and mortality was found. This 
is probably due to the fact that mf-injected mice to not undergo immunomodulation as 
chronic infected mice do. Importantly, another study that used chronic L.s.-infected cotton 
rats for co-infection experiments with M. tuberculosis also found improved bacterial killing 
and resolution of infection (Hübner et al., 2012b). Of note, all studies that investigated the 
impact of L. sigmodontis infection on bacterial infections found that bacteria were cleared 
more efficiently and reduced pro-inflammatory cytokine responses (Gondorf et al., 2015; 
Hübner et al., 2008, 2012b). 
Other studies demonstrated different modes of action exerted by helminth-derived 
compounds: blocking of the LPS receptor complex (TLR4, LBP, CD14) (Panda et al., 2013, 
2012; Robinson et al., 2011) and manipulation of TLR4-derived intracellular signaling 
(Goodridge et al., 2005; Turner et al., 2006). The possibility that LPS-sensing was abrogated 
by blocking of the LPS receptor complex in this study is unlikely, because outcomes of co-
infection and macrophage transfer experiments were dependent on TLR2. This suggests 
that TLR4 derived signaling is not blocked directly by compounds like chitohexaose (Panda 
et al., 2012), FhDM1 (Robinson et al., 2011) or circulating filarial antigen (CFA) (Panda et al., 
2013), but rather that TLR2-derived intracellular signaling conveyed hypo-responsiveness 
to E. coli-LPS.  
The first hints that filaria-derived Wolbachia may induce hypo-responsiveness to 
subsequent LPS-stimulation stem from a study that determined the effects of Brugia 
malayi antigen (BmAg) preparations on subsequent LPS challenge (Turner et al., 2006). TLR- 
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and CD40L-induced signals were reduced following BmAg treatment. All of the experiments 
were done in vitro, except for an in vivo model of endotoxemia (LPS challenge). Our 
findings are in accordance with the study by Turner et al. (2006) and add to the picture that 
live infections with L.s. similarly induce macrophage reprogramming in a TLR2 dependent 
manner and that LsAg preparations act similarly to Brugia malayi extract. Taken together, 
the data from the study by Turner et al. (2006) and from the current thesis one may 
speculate that filarial infections in humans may similarly employ TLR2 for 
immunomodulation. Indeed, literature provides some support for this issue in Wucheria 
bancrofti (Babu et al., 2011) and Brugia malayi (Turner et al., 2009) infections. This is 
further supported by reports which found that TLR2 polymorphisms may account for 
severe pathology or resistance to infection (Hise et al., 2003; Junpee et al., 2010). 
Endotoxin tolerance occurs after exposure to bacterial lipopolysaccharide (LPS) and 
probably evolved as a protective mechanism to avoid exacerbated inflammation and 
immune mediated pathology (Ayres and Schneider, 2012; Biswas and Lopez-Collazo, 2009; 
Fan and Cook, 2004). Besides LPS, several other pathogen-derived molecular patterns 
(PAMPs), but also endogenous factors (e.g. TNF, HMGB1) were shown to induce tolerance 
to subsequent stimulation with TLR ligands (Biswas and Lopez-Collazo, 2009). 
Relevance for the induction of homo-tolerance and hetero-tolerance by TLR2-ligation has 
been previously shown in sepsis models and bacterial challenge infections (Deiters et al., 
2003; Dobrovolskaia et al., 2003; Feterowski et al., 2005; Lehner et al., 2001b; Moreira et 
al., 2008; Musie et al., 2014; Shi et al., 2011; Wheeler et al., 2009). Furthermore, several 
studies demonstrated that in vivo administration of TLR2 ligands improved outcomes in 
models of chronic inflammation and autoimmune disorders (Kim et al., 2011; Pålsson-
McDermott and O’Neill, 2007). Several reports also observed TLR2-dependent helminth-
mediated attenuation of chronic inflammation and autoimmune diseases (Correale and 
Farez, 2009; Onguru et al., 2011; van Riet et al., 2009; Robinson et al., 2011). 
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4.5 Implications for human sepsis 
Although human data on the impact of filarial infection on sepsis is limited, there are 
indications that findings from our study can be translated to human filarial infections. For 
example, it was reported that innate cells from filariae-infected individuals have 
significantly reduced expression and function of toll-like receptors (Babu et al., 2005, 2009; 
Semnani et al., 2008). Similarly, it was shown by Arndts et al. (2012) and Sasisekhar et al. 
(2005) respectively, that PBMCs and monocytes from Wuchereria bancrofti-infected 
individuals produce lower concentrations of pro-inflammatory cytokines following LPS 
stimulation (Arndts et al., 2012; Sasisekhar et al., 2005). Panda et al. (2013) also reported a 
reduced production of pro-inflammatory cytokines in response to LPS by monocytes 
derived from filariasis patients. The authors of this study proposed that circulating filarial 
antigens (CFA) block TLR4 which reduces LPS-induced monocyte activation (Panda et al., 
2013). While a similar mechanism may occur in chronically infected L. sigmodontis mice, 
transfer experiments using TLR2 deficient mice suggest that blocking of TLR4 by CFA is not 
the mode of action in this thesis. The only epidemiologic study that directly investigated 
the influence of filarial infection on sepsis in humans also concludes that filarial infections 
may indeed have beneficial effects on sepsis. In this study only a minority of the sepsis 
patients examined was CFA-positive (6.7%), whereas the incidence of CFA-positive 
individuals was significantly higher in healthy endemic controls (42.7%) (Panda et al., 
2013). This suggests that pre-existing filarial infections may reduce the risk to develop 
sepsis. 
Thus, chronic filarial infections may help to maintain a balanced immune system during 
severe bacterial infections and prevent sepsis by functionally modulating macrophages to 
enhance anti-bacterial functions and alleviate cytokine secretion in response to TLR 
ligation. As a consequence of rapid containment of the bacteria and reduced pro-
inflammatory cytokine secretion, systemic inflammation and associated immune-pathology 
is attenuated and provides a survival benefit.  
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4.6 Epigenetic imprints 
Recently, a novel epigenetic concept termed “trained immunity” or “innate memory” was 
postulated (Quintin et al., 2014; Saeed et al., 2014). Especially macrophages are thought to 
gain functional advantages through the prior encounter of related or unrelated pathogens 
(or derived patterns thereof) leading to improved resistance to subsequent infections 
(Cheng et al., 2014; Kleinnijenhuis et al., 2012; Quintin et al., 2012). Interestingly, it was 
demonstrated that this phenomenon is controlled by specifically induced DNA or histone 
methylation events, rather than a broad and unspecific refractoriness or exhaustion state. 
This epigenetic imprinting permits innate cells to establish an immune memory that can 
help to fight pathogens more efficiently in subsequent encounters. DNA-, but also histone 
methylation is thought to direct gene transcription at the chromatin level and thereby 
regulates functional behavior of immune cells. I speculate that L.s. infection evokes 
epigenetic imprinting in innate cells in a similar way. In chronic infection, constant 
exposure to worm-derived molecules may alter DNA and/or histone methylation and 
thereby substantially modulate macrophage responsiveness to subsequent stimuli. 
Epigenetic analyses of immune cells in complex human diseases like helminth infection or 
bacterial sepsis (Ciarlo et al., 2013) have a strong potential to elucidate those underlying 
regulatory events of cell behavior in pathologic situations and should be pursued in future 
studies. 
 
4.7 Outlook 
Incidence of sepsis has been rising over the last decades and is expected to further increase 
in the future. Despite immense research efforts, sepsis and systemic inflammation are still 
poorly predictable and treatment efficacy represents a persistent challenge. Mortality of 
severe sepsis remains high (30-60%) in the overall population, whereas newborn and 
immunocompromised patients are at even higher risk (Angus and van der Poll, 2013; 
Annane et al., 2003; Artero et al., 2008; Koch, 2015; Morrell et al., 2009). 
On the other hand, strong immune reactions often cause collateral damage to tissues and 
organs and thereby may further compromise patient health. Sepsis is characterized by an 
excessive systemic response in order to clear pathogens leading to severe pathophysiologic 
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symptoms. As opposed to those resistance-focused responses that likely cause 
immunopathology, disease tolerance mechanisms contribute to a balanced immune 
response that limits damage to host fitness by the cost of increased pathogen loads (Ayres 
and Schneider, 2012; Medzhitov, 2013; Medzhitov et al., 2012). Tolerogenic treatment 
strategies that employ the plasticity of macrophages in order to prevent exacerbated 
inflammation without impairing bacterial clearance are highly desirable and may present 
new therapeutic avenues to improve sepsis survival in humans  
Regarding filariasis, future clinical and field studies in co-endemic areas should provide 
more insight to the complex crosstalk between filarial and bacterial infections in humans. 
Of note, the possible consequences of mass drug administration in helminth-endemic areas 
(Wammes et al., 2014) on incidence and outcome of severe concurrent (bacterial) 
infections should be also taken into consideration. 
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6 Appendix 
6.1 Table S1 
Table S1. List of genes included in the PCR array analysis. Displayed are fold-changes and p-values 
of genes expressed in macrophages derived from L. sigmodontis infected, L. sigmodontis infected 
and E. coli challenged as well as E. coli-only challenged mice in comparison to macrophage gene 
expression of naïve mice. 
 
L. sigmodontis E. coli L.s.+ E. coli 
Symbol Fold-change p-value Fold-change p-value Fold-change p-value 
CCL24, Eotaxin-2 2.15 0.1463 3.93 0.0295 2.10 0.2747 
BTK -1.42 0.2702 1.25 0.4727 1.28 0.4845 
C/EBP -2.37 0.0523 7.33 0.0025 9.49 0.2522 
IKKa 2.17 0.1944 1.35 0.4613 1.58 0.1307 
IKKe 1.64 0.3995 9.39 0.0028 31.33 0.2238 
cFos 1.04 0.8569 1.48 0.5169 -1.32 0.9408 
IRAK-1 -1.22 0.4894 1.55 0.1036 -1.00 0.8531 
IRF1 1.14 0.5821 36.29 0.0120 22.25 0.2279 
IRF3 1.58 0.3265 1.59 0.2095 1.31 0.4662 
IRF5 -2.05 0.0349 4.81 0.0763 4.83 0.0000 
IRF7 1.83 0.3897 2.02 0.5265 3.46 0.2282 
cJun, AP-1 -1.30 0.5233 3.50 0.0021 2.71 0.0181 
MyD88 -1.31 0.6983 5.42 0.0003 5.23 0.2185 
NFkB, p50, p105 -2.01 0.0842 3.96 0.0224 3.29 0.0002 
NFkB, p52, p100 -2.43 0.3858 3.87 0.0666 6.20 0.0112 
IkBbeta -1.94 0.0465 8.23 0.0006 5.58 0.0238 
IKKb -1.20 0.8819 5.97 0.0143 3.65 0.0289 
PPARa -1.32 0.8331 13.94 0.0628 1.84 0.3715 
PPARg 2.76 0.3199 16.16 0.0668 9.87 0.0012 
NFkB, cRel -3.46 0.0350 1.02 0.9394 -1.06 0.6713 
NFkB, RelA, p65 -3.46 0.0361 3.17 0.0340 2.03 0.0238 
NFkB, RelB -2.21 0.0155 -1.36 0.1398 1.69 0.1033 
HMGB1 1.17 0.5135 -1.85 0.0321 -2.13 0.0460 
RICK/RIP2 1.29 0.2954 -1.62 0.1695 -1.01 0.9562 
TRIF -2.87 0.0179 6.94 0.0193 5.31 0.0242 
TRAM -1.96 0.0848 -2.37 0.1391 -2.89 0.0228 
Mal/Tirap -1.78 0.1059 1.59 0.2380 2.71 0.3088 
A20/ TNFAIP3 -1.84 0.2331 11.09 0.0530 12.96 0.0476 
TOLLIP -1.71 0.1722 5.30 0.0161 3.60 0.0316 
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TRADD 2.42 0.2310 1.65 0.2826 1.52 0.4138 
Traf6 -2.89 0.0120 1.58 0.1444 1.21 0.4613 
CD14 2.08 0.1667 -1.14 0.9811 1.58 0.4431 
CD80 -1.64 0.2804 4.14 0.0359 2.56 0.0518 
CD86 -1.62 0.4151 3.41 0.0334 1.27 0.5688 
MD2 1.71 0.3922 1.40 0.6532 2.89 0.2378 
TLR1 1.21 0.5248 -2.04 0.0571 1.20 0.4770 
TLR2 -1.36 0.4235 1.36 0.3549 3.12 0.2475 
IRAK-4 1.39 0.2166 1.04 0.8122 1.24 0.5462 
TLR4 1.38 0.6640 1.88 0.3178 3.38 0.2733 
TLR6 -1.53 0.2733 -2.83 0.2196 1.26 0.3901 
TNFaR 1.19 0.7069 2.12 0.2250 3.19 0.3451 
CD40 1.03 0.7069 4.14 0.0001 3.07 0.0600 
CCR2 1.01 0.7116 2.79 0.1925 2.87 0.2264 
CCR5 1.20 0.7101 -2.79 0.1453 -1.15 0.8073 
IRAK-M -1.19 0.4889 1.99 0.0492 4.42 0.2185 
Leptin Receptor 14.42 0.0884 23.77 0.0690 9.66 0.2899 
IFN (alpha,beta) 
receptor 1 -1.52 0.7015 4.34 0.0040 6.47 0.1137 
CCL22 -9.54 0.1551 1.69 0.5060 1.37 0.8470 
IL1RA 1.59 0.4865 41.39 0.0455 59.82 0.1496 
M-CSF -1.47 0.5385 32.18 0.0167 12.63 0.1843 
GM-CSF -1.07 0.9923 14.20 0.0190 5.68 0.3558 
CXCL10, IP-10 5.72 0.3771 545.46 0.0340 276.79 0.3337 
IFNb 5.53 0.3612 47.88 0.0543 8.22 0.0741 
IFNg -1.29 0.5093 39.52 0.0492 24.30 0.3726 
C5aR 1.43 0.3372 4.29 0.0945 11.05 0.2639 
CCL2/MCP1 1.93 0.4045 -4.24 0.0224 -2.49 0.3281 
TNFa -2.68 0.0904 17.85 0.0407 26.77 0.1463 
IL10 -9.54 0.1504 9.59 0.0081 7.03 0.0244 
IL12p35 -1.53 0.3970 6.00 0.0044 6.88 0.1671 
IL1b 1.82 0.3321 5.64 0.1440 10.10 0.2639 
IL6 -5.72 0.1656 -11.38 0.1249 -8.21 0.1563 
Socs1 -2.29 0.2154 38.53 0.0281 31.76 0.1644 
Socs3 -1.82 0.1754 3.02 0.0432 7.36 0.2705 
CD11b/ 
CR3/Mac-1 1.47 0.7668 2.69 0.0935 2.65 0.3753 
SHIP-1 -1.11 0.8178 9.39 0.0165 4.95 0.0016 
MBL 2.43 0.4023 114.40 0.0527 11.95 0.2039 
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NOD2 1.55 0.4490 22.75 0.0002 28.23 0.1958 
C3 1.69 0.3609 4.64 0.0029 11.73 0.2479 
iNOS 1.24 0.4051 56.94 0.0196 271.72 0.3338 
COX2 -2.29 0.2580 4.73 0.2833 5.07 0.2584 
IL1R -2.85 0.6434 2.88 0.1309 2.32 0.2584 
IL6R -1.22 0.6691 2.56 0.1144 5.11 0.0045 
YM1 2.68 0.2912 212.50 0.0013 1280.66 0.1127 
AMCase 1.68 0.7528 18.23 0.0654 2.76 0.3749 
MR 6.70 0.0181 12.86 0.0545 5.46 0.0076 
RELMa 6.59 0.3196 36560.55 0.0089 10174.47 0.2411 
IL4 -1.31 0.7967 77.78 0.0013 5.16 0.0750 
IL4Ra -1.44 0.7776 4.29 0.0094 6.95 0.1525 
Cx3CR1 -1.11 0.9211 19.49 0.0638 3.10 0.2559 
IL13 1.23 0.5616 51.55 0.0996 8.73 0.0483 
ST2 -2.70 0.2864 2.07 0.2673 -4.40 0.2100 
IL33 -1.12 0.4654 12.62 0.0725 8.75 0.2670 
TGFb -1.09 0.9970 4.14 0.0010 2.30 0.0407 
CD273/PD-
L2/B7-DC -1.63 0.5369 8.44 0.0032 2.96 0.1576 
Arginase 1 3.85 0.3820 -7.35 0.2365 -1.96 0.6440 
F4/80 2.64 0.0499 -1.47 0.2654 -4.86 0.0218 
PPARd -1.38 0.0196 1.24 0.4139 2.51 0.0739 
CCL8 /MCP2 105.18 0.3074 114.40 0.0527 26.10 0.2928 
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6.2 Abbreviations 
AAM  alternatively activated macrophages 
bp   base pair 
°C   degree Celsius 
CCL / CCR  chemokine (c-c motif) ligand / receptor 
cfu  colony forming units 
DMSO   Dimethyl sulfoxide 
dpi   days post infection 
FCS  fetal calf serum 
FITC  Fluorescein isothiocyanate 
FSC  forward scatter 
GFP  green fluorescent protein 
GM-CSF granulocyte macrophage colony stimulating factor 
hi  high expressing 
HLA  human leukocyte antigen 
HRP  horseradish peroxidase 
IFN  interferon gamma 
Ig  Immunoglobulin 
IL-   interleukin- 
IL-1Ra  interleukin-1 receptor antagonist 
IL-4R  Interleukin-4 receptor alpha chain 
i.p.  intra-peritoneal 
i.v.  intra-venous 
ko/k.o.  knock-out 
LB  lysogeny broth 
LBP  LPS binding protein 
lo  low expressing 
LPS   lipopolysaccharide 
L.s.  Litomosoides sigmodontis 
LsAg  Litomosoides sigmodontis antigen 
Ls-tet  antigen from tetracycline-treated L.s. adult worms 
MACS  magnet activated cell sorting 
M   molarity (mol/L) 
med.   medium (RPMI1640) 
mf  microfilariae 
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MFI  mean fluorescence intensity 
MHC   mayor histocompatibility complex 
ml  milliliter 
MyD88 myeloid differentiation primary response protein 88 
M  macrophage(s) 
NO   nitric oxide 
NOD  non-obese diabetic mice 
NOS   nitric oxide synthase 
OD  optical density 
o/n   over night 
Pam3Cys, P3C Pam3Cys-Ser-(Lys)4, Trihydrochloride 
PBMC   peripheral blood mononuclear cells 
PBS   phosphate buffered saline 
PCR   polymerase chain reaction 
PE  phycoerythrin 
PFA  para-formaldehyde 
PI  propidium iodide 
rpm  pounds per minute 
RT   room temperature 
RT-PCR  realtime PCR 
SIRS  systemic inflammatory response syndrom 
SSC  side scatter 
Treg   regulatory T cell 
TGF  transforming growth factor beta 
Th  T helper cell 
TIR  Toll/IL-1 receptor homology domain 
TIRAP  TIR domain containing adaptor protein 
TLR  toll-like receptor 
TMB  tetramethybenzidine 
TNF  tumor necrosis factor 
U  uninfected (in terms of L.s. infection) 
WT/Wt wild type 
#  number/ count 
+/-  positive/negative      
 121 
 
6.3 Curriculum Vitae 
Mr. Fabian Gondorf, Dipl. Biol. 
 
Education and Scientific Career 
8/2010-10/2014 Dissertation: 
“Molecular Biomedicine” at the Institute for Medical Microbiology, 
Immunology and Parasitology (IMMIP), University Hospital Bonn, 
Group of Dr. Marc Hübner (Director: Prof. Dr. Achim Hoerauf) 
 
10/2003-1/2010  Academic Studies: 
Biology at the University of Bonn (RFWU, diploma degree) 
Main-Subjects: Immunobiology (Zoology), Cell-biology, Biochemistry 
Minor-Subjects: Genetics, Microbiology and Biotechnology, 
Bioinformatics, Neurobiology, Physiology, Developmental Biology 
Diploma-thesis at the Department of Immunobiology, (Director: Prof. 
Dr. N. Koch), Title: “Expression of BAT3 splice variants in monocytes 
and exosomes”  
 
2002-2003  Civilian Service at DRK-Hospital, Altenkirchen, RLP 
 
2002   High School: Westerwald-Gymnasium, Altenkirchen  
Abitur (german university entrance degree)  
6 Appendix 
 
122 
 
6.4 Scientific contributions 
6.4.1 Conferences, trainings and schools 
Participation and oral presentation at 16th Symposium „ Infection and Immune-defense“ at Burg 
Rothenfels 8th-10th March, 2012 (DGHM, DGfI); 3rd prize “Best Presentation” (Talk title: “Helminth 
infection improves E. coli induced hypothermia and bacterial clearance”) 
 
Participation in successful BONFOR grant expansion proposal by Dr. Hübner. Generation of 
preliminary data and graphs. (grant proposal title: „Helminthen-vermittelte Hemmung einer 
systemischen Entzündungsreaktion im Mausmodell“ M.P. Hübner, F. Gondorf, D. Blömker, A.-L. 
Neumann, S. Specht, A. Hoerauf; grant number: 0-150.0052) 
 
Animal experimentation course (FELASA, cat. B) at “Haus für experimentelle Therapie“ of the 
Medical Faculty of the University of Bonn. (German; 40 hours, March 2013) 
 
Participation in the “ImmunoRegulation Symposium” of the SFB704, 22th-23th April, 2013 at 
Caesar, Bonn) 
 
Participation in successful DFG grant proposal by Dr. Hübner. Generation of preliminary data and 
graphs for this application. (Grant title: “Crosstalk of macrophages and eosinophils in helminth-
mediated protection during experimental sepsis” M.P. Hübner; grant number: HU2144/1-1) 
 
Participation and poster presentation at “9th Spring School of Immunology” 10th-15th March, 2013, 
Ettal (DGfI) (Poster title: “Chronic helminth infection improves bacterial clearance and E. coli 
induced inflammation in a TLR2 dependent manner” F. Gondorf, A. Hoerauf, M. P. Hübner) 
 
Participation and poster presentation at “43th Annual Meeting of the German Society for 
Immunology (DGfI), 11th-14th September, 2013, Mainz. (Poster title: “Chronic filarial infection 
improves E. coli induced sepsis through a TLR2-mediated cross-tolerance mechanism”, F. Gondorf, 
A. Hoerauf, M. P. Hübner) 
 
Participation and abstract at “Science Day 2013” of the “Immunosensation excellence cluster”, 
Bonn, 22th October, 2013 (Abstract title: “Chronic exposure to filaria and its endosymbiotic 
Wolbachia bacteria improves E. coli induced sepsis in a TLR2 dependent manner” F. Gondorf, A. 
Hoerauf, M. P. Hübner) 
6 Appendix 
 
123 
 
 
Participation in “Writing Papers and Theses in the Life Sciences” course by Prof. Wild, MPI 
Münster. (Bonn, 24th March, 2014)  
 
Participation and poster presentation at “DZIF Summer School on Infection Research” (Dresden, 
22th-27th June, 2014); (Poster title: “Macrophage tolerance induction during chronic filarial 
infection is required to improve sepsis” F. Gondorf, A. Hoerauf, M. P. Hübner) 
 
Scientific talk and poster presentation at “44th Annual Meeting of the German Society for 
Immunology (DGfI), 17th-20th September, Bonn. (Talk/Poster title: “Induction of tolerant 
macrophages improves sepsis outcome”) 
 
Participation and scientific talk at “International Filariasis Meeting 2014” (26th -27th September, 
2014, Natural History Museum, Paris, France); (Talk title: “Chronic Litomosoides sigmodontis 
infection improves gram-negative sepsis via TLR2 dependent macrophage modulation”) 
 
Participation and poster presentation at “Science Day 2014” of the “Immunosensation excellence 
cluster”, Bonn, 3rd-4th November, 2014 (Poster title: “Induction of tolerant macrophages improves 
sepsis outcome”) 
 
 
My project was presented at international conferences (e.g. ASTMH, Hydra, Woods Hole 
Immunoparasitology and others) by my group leader Dr. Marc Hübner.  
 
I am a member of the German Society for Immunology (DGfI) and of the graduate school of the DFG 
Cluster of Excellence “Immunosensation” “International Immunology Training Program Bonn 
(IITB)”. 
  
6 Appendix 
 
124 
 
6.4.2 Mentoring and support of student’s theses: 
Jesuthas Ajendra: (2011, Diploma thesis, title: “Die Rolle des Interleukin-33 Rezeptors ST2 
während der Infektion mit Litomosoides sigmodontis“) 
 
Dominique Blömker: (2012, Diploma thesis, title: Einfluss einer Infektion mit der 
Nagetierfilarie Litomosoides sigmodontis auf die Funktion peritonealer Phagozyten im 
Sepsis-Modell“) 
 
Benedikt Buerfent: (2013, Diploma thesis, title: “Einfluss einer chronischen Filarieninfektion 
auf die Entwicklung einer E. coli-induzierten Immunparalyse“)  
 
Constanze Kühn: (2013/14, Master thesis, title „Immunmodulation durch Filarienantigen im 
Mausmodell und erste Charakterisierung der aktiven Komponente“) 
 
I was further involved in experiments of the PhD students in Dr. Hübner’s group: Afiat 
Berbudi (Diabetes and filarial infection), Jesuthas Ajendra (NOD2 and filarial infection) and 
Benedikt Bürfent (eosinophils in the context of filaria/bacteria co-infections). 
 
 
 
  
6 Appendix 
 
125 
 
6.4.3 Publications in peer-reviewed journals: 
 
Helminth protection against autoimmune diabetes in nonobese diabetic mice is 
independent of a type 2 immune shift and requires TGF-β. 
Hübner MP, Shi Y, Torrero MN, Mueller E, Larson D, Soloviova K, Gondorf F, Hoerauf A, Killoran KE, Stocker JT, Davies SJ, 
Tarbell KV, Mitre E. 
J Immunol. 2012 Jan 15;188(2):559-68. doi: 10.4049/jimmunol.1100335. Epub 2011 Dec 14. 
 
 
ST2 deficiency does not impair type 2 immune responses during chronic filarial infection 
but leads to an increased microfilaremia due to an impaired splenic microfilarial 
clearance. 
Ajendra J, Specht S, Neumann AL, Gondorf F, Schmidt D, Gentil K, Hoffmann WH, Taylor MJ, Hoerauf A, Hübner MP. 
PLoS One. 2014 Mar 24;9(3):e93072. doi: 10.1371/journal.pone.0093072. eCollection 2014. 
 
 
E. coli-induced immune paralysis is not exacerbated during chronic filarial infection 
Buerfent BC, Gondorf F, Wohlleber D, Schumak B, Hoerauf A, Hübner MP. 
Immunology. 2015 May;145(1):150-60. doi: 10.1111/imm.12435. 
 
Chronic filarial infection provides protection against bacterial sepsis by functionally 
reprogramming macrophages. 
Gondorf F, Berbudi A, Buerfent BC, Ajendra J, Bloemker D, Specht S, Schmidt D, Neumann AL, Layland LE, Hoerauf A, 
Hübner MP. 
PLoS Pathog. 2015 Jan 22;11(1):e1004616. doi: 10.1371/journal.ppat.1004616. eCollection 2015 Jan. 
 
Parts of this thesis are published in: 
Gondorf F, Berbudi A, Buerfent BC, Ajendra J, Bloemker D, Specht S, et al. (2015) Chronic 
Filarial Infection Provides Protection against Bacterial Sepsis by Functionally 
Reprogramming Macrophages. PLoS Pathog 11(1): e1004616. doi:10.1371/journal. 
ppat.1004616  
6 Appendix 
 
126 
 
6.5 Acknowledgements 
I thank Prof. Dr. Achim Hörauf for the opportunity to realize my PhD thesis at the Institute 
of medical microbiology, immunology and parasitology at the University Hospital of Bonn. 
I appreciate the work and commitment of the members of the examination committee: 
Prof. Dr. Joachim Schultze, Prof. Dr. Achim Hörauf, Prof. Dr. Christoph Thiele and Prof. Dr. 
Volker Knoop. 
I thank Dr. Marc Hübner for active participation and excellent supervision of the scientific 
process in my project, acquisition of funding, lively discussions, large amounts of patience 
and for providing an outstanding, team-oriented and cooperative working atmosphere in 
his group.  
Special thanks for discussions, input and the great teamwork to the recent and former 
group members of the Hübner’s group (in chronologic order): Jesuthas Ajendra, Anna-Lena 
Neumann, Dominique Blömcker, Afiat Berbudi, David Schmidt, Constanze Kühn and 
Benedikt Buerfent. 
Very special thanks to my former office mates Dr. Kim E. Schmidt, Dr. Jennifer Vollmer and 
Dr. Anna Albers for lively discussions and a warm and cooperative atmosphere.  
I am grateful for the lively exchange with staff and students of neighboring research groups 
in the IMMIP (AG Specht, AG Schumak, AG Pfarr, AG Layland) and institute’s facilities 
(secretary, media preparation, animal facilities) that contributed to a sophisticated and 
convenient working atmosphere at the IMMIP. 
I thank BONFOR for intramural funding of Dr. Marc Hübner’s junior research group (2010-
2012) and the “Deutsche Forschungsgemeinschaft, DFG” for funding this research project 
(since 2012). 
Most credits go to my love Katarina Kuss, without her wisdom, understanding and mental 
support, I would not have been able to complete this thesis. 
Zum Schluss, aber nicht letztens, ein Gruß an die Familien. Ich liebe euch. 
